TABLE OF CONTENTS
Page
Welcome from the Chairpersons of the 8th ESSM Congress. . . 2
Welcome from the ESSM President . . . . . . . . . . . . . . . 3
ESSM History . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
ESSM Committees . . . . . . . . . . . . . . . . . . . . . . . . . 5
ESSM Award Winners . . . . . . . . . . . . . . . . . . . . . . 6
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . 7
Bella Center Copenhagen - Floorplan . . . . . . . . . . . . . . 7
General Information
Congress Registration Counter
Registration Fees . . . . . . . . . .
Congress Language . . . . . . . .
Congress Documentation . . . .
Congress Information System
CO CONGRESS ONLINE® . .
Speakers Centre and Lounge .
ESSM Membership Issues . . . .
Name Badges . . . . . . . . . . . .
Technical Exhibition . . . . . . . .
Poster Exhibition . . . . . . . . . .
Poster CD ROM. . . . . . . . . . .
Internet Centre. . . . . . . . . . . .
Press . . . . . . . . . . . . . . . . . .
Messages . . . . . . . . . . . . . . .
Restaurants . . . . . . . . . . . . . .
Coffee Breaks . . . . . . . . . . . .
Cloakroom . . . . . . . . . . . . . .
Bank . . . . . . . . . . . . . . . . . .
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.9
.9
.9
.9
.9
.9
10
10
10
10
10
10
10
10
CONGRESS AND EXHIBITION OFFICE
CPO HANSER SERVICE GmbH
P.O. Box 1221
D-22882 Barsbüttel
Telephone: +49-40-670 88 20
Telefax:
+49-40-670 32 83
E-mail:
[email protected]
ESSM SECRETARIAT
Lavinia Ricci
c/o AISC & MRG srl AIM Group
Via Ripamonti 129
I-20141 Milan
Telephone: +39-025-6601 289
Telefax:
+39-027-0048 577
E-mail:
[email protected]
8
8
8
9
Page
Currency . . . . . . . . . . . .
Electricity . . . . . . . . . . . .
Lost and Found . . . . . . . .
Mobile Phones . . . . . . . .
Program Changes . . . . . .
Insurance . . . . . . . . . . . .
Hospitality Suites . . . . . . .
Airport . . . . . . . . . . . . . .
Car Park. . . . . . . . . . . . .
Taxis . . . . . . . . . . . . . . .
Public Transportation Pass.
Copenhagen Metro Map .
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
10
10
10
10
11
11
11
11
11
11
11
11
Social Events. . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Supporting Program . . . . . . . . . . . . . . . . . . . . . . 12
Introduction to the Scientific Program
Format Descriptions . . . . . . . . . . . . . . . . . . 14
CME Credits . . . . . . . . . . . . . . . . . . . . . . . 15
Awards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Program Schedule . . . . . . . . . . . . . . . . . . . . . . . . 16
Scientific Program
Sunday, 4 December 2005 . . .
Monday, 5 December 2005 . . .
Tuesday, 6 December 2005 . . .
Wednesday, 7 December 2005
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
21
22
30
36
Poster Presentations . . . . . . . . . . . . . . . . . . . . . . 41
List of Exhibitors and Exhibition Floorplan . . . . . . . . . . 54
List of Chairpersons and Presenters . . . . . . . . . . . . . 55
SCIENTIFIC SECRETARIAT
Petter Hedlund
Department of Clinical Pharmacology
Lund University Hospital
S-22185 Lund
Telephone: +46-46-173 351
Telefax:
+46-46-211 1987
E-mail:
[email protected]
CONGRESS VENUE
Bella Center
Center Boulevard 5
DK – 2300 Copenhagen S
1
WELCOME FROM THE CHAIRPERSONS
OF THE 8TH ESSM CONGRESS
Dear Colleagues and congress participants,
We are delighted to welcome you to Copenhagen to participate in the
8th Annual Meeting of the European Society for Sexual Medicine (ESSM). At this
time of year, Copenhagen and the region of Öresund are preparing for
Christmas Celebrations and we hope that the Scandinavian atmosphere of the
season will embrace you all during your stay in Denmark.
The main aims of the 8th ESSM Congress are to bring forward the latest advances in the understanding of sexual physiology and improved knowledge of the
association of health-risk factors and sexual dysfunctions, as well as advances
in preventive, diagnostic and therapeutic options for various forms of male and
female sexual dysfunctions. The Scientific Committee has made great efforts to
create a diverse scientific schedule that day-by-day offers interesting titles of
various topics and we are confident that each day will offer something for
everyone.
This year we have extended the scientific program and are running 4 sessions
in parallel. Debates have been introduced into the program to allow for extended opportunities for discussions, and we have added an additional interactive
case-session. Two new instructional courses and one postgraduate course are
also being presented.
We have received more than 400 abstract submissions that include various
aspects from basic and clinical research on male and female sexual medicine,
and the number of abstracts scheduled for moderated sessions or podium presentations has had to be substantially increased.
It has been a challenge, but also a very rewarding experience for us to be part
of the organization the 8th Annual Congress of the ESSM. Throughout this process we have received tremendous support and continuous creative encouragements from the ESSM and its secretariat, CPO HANSER SERVICE, our advisory
board and local organizing committee. We are also honored to be involved in
the 10 Year Anniversary Celebration of our Society which in various events will
be acknowledged through all of the meeting-days in Copenhagen and which
will receive special attention during an exciting evening at the Tivoli Garden.
Welcome,
Petter Hedlund
2
Annamaria Giraldi
WELCOME FROM
THE ESSM PRESIDENT
Dear ESSM Members, Colleagues and Friends,
For more than 10 years ago, during the meeting of the International Society for
Impotence Research organised by Ganesan Adaikan in Singapore, a group of
enthusiastic European investigators came together and discussed a common
vision to establish a new chapter of the history of the mother society. In the interest of better patient care and to promote research initiatives it was agreed by
all to expand the knowledge on sexual dysfunctions in Europe. The European
Society for Impotence Research (ESIR) was born.
Our first and truly “historical meeting”, organised in Greece by our current Past
President Dimitrios Hatzichristou in the beautiful sea-side resort Porto Carras,
contained pure science and discussions from early in the morning to late in the
evening. No Greek "siesta" at all - what a meeting ! Since then, the society started
to grow rapidly. The initially biennial meetings organised by Inigo Saenz de
Tejada in Madrid, Halim Hattat in Barcelona, myself in Rome, and subsequently the annual meetings organized by Hartmut Porst in Hamburg, Emre Akkus in
Istanbul and David Ralph in London were all extremely successful, both in terms
of delegate-attendance and of scientific quality.
My predecessors as Presidents of the Society, Gorm Wagner, Inigo Saenz de
Tejada, John Pryor and Dimitrios Hatzichristou have progressively transformed
the initial small group of experts in the field of sexual dysfunctions into a solid
association composed of more than 1.200 active members. We have adapted
ourselves to changing times and this has been shown by the subsequent changes
of the name of the Society: from ESIR to ESSIR (European Society for Sexual and
Impotence Research) to go beyond the field of male sexual disorders, and
finally to European Society for Sexual Medicine (ESSM) to fully embrace the field
of Sexual Medicine.
This year in Copenhagen we will celebrate the 10th anniversary of the ESSM
and Petter Hedlund and Annamaria Giraldi have invested very much time and
energy in the organization of this wonderful event. The scientific program is solid
and the scientific committee has worked hard to identify key topics of male and
female sexual medicine that will be presented in various forms. Interactive case
sessions and time for discussions have been extended, and we are this year
introducing debates into the program. In addition, novel courses have been
added to our continuously dynamic educational program and the number of free
presentations has been increased to cover the progressively greater amounts of
original scientific submissions to our Society’s meetings. In a new initiative of the
ESSM to its members, we will this year record a large number of sessions, lectures and all instructional courses of the congress in Copenhagen. These will then
be available after the meeting for ESSM members to view on-line though our new
website and we are truly grateful to our academy for their contribution and collaboration to make this happen.
All members of the Executive Committee have been working hard to support
ESSM in their own countries and throughout Europe and we all owe them much
recognition. Many ESSM members have established local affiliated Sexual
Medicine Societies and we do hope that we will soon have a really
pan-European ESSM.
The official journal of ESSM, The Journal of Sexual Medicine, under the energetic
and wise leadership of the Editor in Chief Irwin Goldstein has been rapidly growing in terms of number readers and submitted manuscripts, and has just been
selected to be indexed and included in Medline. Abstracts presented at the
Copenhagen meeting will be published in a dedicated supplement of the Journal.
It is a pleasure for me to welcome you all to our 10 year Anniversary meeting
in Copenhagen.
Francesco Montorsi, President ESSM
3
ESSM HISTORY
PRESIDENT
CHAIRPERSONS OF THE 8TH ESSM CONGRESS
Petter Hedlund, MD Ph.D
Department of Clinical Pharmacology
Lund University Hospital
S-22185 Lund
Telephone: +46-46-173 351
Telefax:
+46-46-211 1987
E-mail:
[email protected]
Prof. Francesco Montorsi
Department of Urology
Universita' Vita Salute San Raffaele
Via Olgettina 60
I-20132 Milan
Telephone: +39-02-2643 7286
Telefax:
+39-02-2643 7298
E-mail:
[email protected]
Annamaria Giraldi, MD Ph.D
Sexological Clinic
Division of Sexological Research
Rigshospitalet section 7111
Blegdamsvej 9
DK - Copenhagen 2100
Telephone: +45-35-4576 79
Telefax:
+45-35-4576 84
E-mail:
[email protected]
ESSM SECRETARIAT
Lavinia Ricci
c/o AISC & MRG srl AIM Group
Via Ripamonti 129
I-20141 Milan
Telephone: +39-025-6601 289
Telefax:
+39-027-0048 577
E-mail:
[email protected]
ESSM PRESIDENTS
1993-1997
1997-1999
1999-2001
2001-2004
2004-2007
Gorm Wagner, Denmark
Inigo Saenz de Tejada, Spain
John Pryor, UK
Dimitrios Hatzichristou, Greece
Francesco Montorsi, Italy
‘Wonderful Copenhagen’, C. van Roeden
ESSM CONGRESS VENUES AND CHAIRMEN
Historical Buildings of Copenhagen
4
1995
Porto Carras, Greece
1997
Madrid, Spain
2000
Barcelona, Spain
Halim Hattat, Turkey
2001
Rome, Italy
2002
Hamburg, Germany
Hartmut Porst, Germany
2003
Istanbul, Turkey
Emre Akkus, Turkey
2004
London, UK
David Ralph, UK
2005
Copenhagen, Denmark
Petter Hedlund, Sweden
2006
Vienna, Austria
Siegfried Meryn, Austria
ESSM COMMITTEES
EXECUTIVE COMMITTEE
President:
Past President:
Secretary
General:
John Dean, United Kingdom
Treasurer:
Ian Eardley, United Kingdom
Members:
Emre Akkus, Turkey
Carlo Bettocchi, Italy
Juza Chen, Israel
Beatrice Cuzin, France
SUB COMMITTEES
Psychosexual
Chairman:
Members:
Basic Science
Chairman:
Members:
Kerstin S. Fugl-Meyer, Sweden
Annamaria Giraldi, Denmark
Antonio Martin-Morales, Spain
Surgery
Chairman:
Members:
SCIENTIFIC COMMITTEE COPENHAGEN 2005
Chairperson:
Members:
Francois Giuliano, France
Geoffrey Hackett, United Kingdom
Ignacio Moncada, Spain
Kevan Wylie, United Kingdom
Loukas Athanasiadis, Greece
Tricia Barnes, United Kingdom
Marie Chevret, France
Chiara Simonelli, Italy
Mehmet Sungur, Turkey
Javier Angulo, Spain
Mario Maggi, Italy
Stefan Ueckert, Germany
Fulvio Colombo, Italy
Ates Kadioglu, Turkey
Sava Perovic, Serbia
David Ralph, United Kingdom
Female Sexual Health
Chairman:
Andrea Solonia, Italy
Members:
Ellen Laan, The Netherlands
Roy Levin, United Kingdom
Primary Care
Chairman:
Members:
Andrea Salonia, Italy
Clinical
Chairman:
Members:
Bert-Jan DeBoer, The Netherlands
David Edwards, United Kingdom
Doug Savage, United Kingdom
Jon Cartledge, United Kingdom
Kostas Hatzimouratidis, Greece
Luca Incrocci, The Netherlands
Suks Minhas, United Kingdom
5
ESSM COMMITTEES
NATIONAL ORGANIZING COMMITTEE
COPENHAGEN 2005
ADVISORY BOARD
Chairperson:
Karl-Erik Andersson, Sweden
Co-Chairperson:
Hans Hedlund, Norway
Members:
Aleksander Giwercman,
Sweden
Osmo Kontula, Finland
Ellids Kristensen, Denmark
Lars Ny, Sweden
Jörgen Oldbring, Sweden
Ulf Simonsen, Denmark
Trygve Talseth, Norway
ESSM AWARD WINNERS
ESSM AWARD WINNERS
ESSM AWARD WINNERS
Best Presentation Awards
Carreer Awards
1995
Christian Stief, Germany
2002
John Pryor, United Kingdom
1997
Engelhardt, Germany
2003
2004
Giles Brindley, United Kingdom
2000
Apostolos Apostolidis, Greece
F. Mumtaz, United Kingdom
Award of Excellence
2002
2002
2003
2003
Selim Cellek, United Kingdom
Ilan Gruenwald, Israel
2004
Mustafa Usta, Turkey
Alberto Briganti, Italy
2004
Byoung Ahn, Republic of Korea
Antonio Aversa, Italy
6
Ronald Virag, France
ACKNOWLEDGEMENTS
The organizers of the 8th Congress of the European Society for Sexual Medicine gratefully acknowledge the
support of the following companies (as per November 2005).
MAJOR SPONSORS
Bayer HealthCare
Lilly ICOS
Janssen-Cilag
Pfizer Inc.
SPONSORS
AMS
Ipsen Pharma
Mentor-Porges
Nature Publishing
Procter & Gamble
Schering AG
Uroan 21
BELLA CENTER COPENHAGEN - FLOORPLAN
GROUND FLOOR
FIRST FLOOR
Smaller meeting rooms and the Press Office are located on the first floor above the Auditorium.
7
GENERAL INFORMATION
CONGRESS REGISTRATION COUNTER
Registration / Check-in and arrival at the Congress
All Congress materials and documentation will be available at the Congress Registration Counter located in
the Entrance Foyer of the Bella Center.
ESSM Members,
Physicians (MD)
EUR 500
Non--Members,
Physicians (MD)
EUR 600
Opening hours:
ESSM Members with reduced fees
Nurses, Residents in Training*,
Scientists (PhD), Psychologists,
Therapists, Students*
EUR 400
Non- Members with reduced fees
Nurses, Residents in Training*,
Scientists (PhD), Psychologists,
Therapists, Students*
EUR 500
Retired Delegates
EUR
80
Accompanying Persons
EUR
85
Sunday
4 December
Monday
5 December
Tuesday
6 December
Wednesday
7 December
2005
8.00 - 19.30 h
2005
7.00 - 19.30 h
2005
7.30 - 18.00 h
2005
7.30 - 13.00 h
During these opening hours the Congress Counter
can be reached at:
Telephone: +45 3262 2514
+45 3262 2518
Telefax:
+45 3262 2508
The Congress Counter has been divided into the following
sections:
On-Site Registration
On-site registration for the Congress.
Pre-Registration
Participants who have already registered for the
Congress will receive their documents here.
Social Events
Tickets are limited but can still be purchased on-site
for the Gala Evening at the Tivoli Copenhagen on
6 December 2005.
For details please see Social Events on page 12.
Hotel Reservations
Assistance for the reservation of hotel rooms in
Copenhagen will be provided here.
Information
The staff of the information counter will be pleased to
provide you with information about the Congress, the
Congress Center, the hotels and the city of
Copenhagen. They will also assist with restaurant
information.
8
REGISTRATION FEES
The registration fees are including 17,5% UK VAT.
* A letter of the Chairman of the Department is necessary.
Registration fee for participants includes:
n Admission to all scientific sessions
n Conference materials (delegate bag with name
badge, final program, abstract book, etc.)
n Coffee breaks in the morning and afternoon
n Admission to poster and technical exhibition
n Opening Ceremony and Welcome Reception on
4 December 2005
n Public transportation pass during the Congress
from 4 to 7 December 2005
Registration fee for accompanying persons includes:
n Opening Ceremony and Welcome Reception on
4 December 2005
n City sightseeing tour of Copenhagen
n Public transportation pass during the Congress
from 4 to 7 December 2005
CONGRESS LANGUAGE
The Congress language is English. Simultaneous
translation will not be provided.
GENERAL INFORMATION
CONGRESS DOCUMENTATION
The ESSM will offer to its members as a new initiative to view parts of the scientific schedule online
through a web-based system from the new ESSM
homepage. Therefore several lectures will be filmed
during the congress.
CONGRESS INFORMATION SYSTEM
www.essm2005.org
Participants can benefit from the web based ESSM
Congress Information System CO CONGRESS
ONLINE® on-site in the Exhibition Hall at the internet
centre: They can set up and print out a personal congress program schedule. The ESSM Congress
Information System provides information on:
n Updated scientific programme
n Program by day
n Program by formats with accepted abstracts of
chairpersons and speakers
n Program search
SPEAKERS CENTRE AND LOUNGE
The speakers centre and lounge are located in room
Focus, accessible via the Exhibition Hall of the ESSM
congress. Speakers are asked to hand in their CD
ROM or USB stick, containing the PowerPoint presentation (IBM format or compatible, no multisession)
preferably one day before their presentation but at
latest 90 minutes prior to the presentation. The presentation will be transferred to the central congress
server and will be available afterwards on a special
congress notebook in the hall of the presentation.
Due to time and technical reasons we kindly ask the
speakers not to use their own notebook. In the speakers centre there are several PC working stations
where speakers can also work on their PC charts in
a quiet area. Technical staff will be glad to assist.
A speakers lounge is provided in a separate area of
room Focus. Please see as well page 7.
ESSM MEMBERSHIP ISSUES
For ESSM membership issues and any other ESSM
business, please contact our ESSM booth which is
situated in the exhibition area.
NAME BADGES
All participants are strongly requested to wear their
name badge at all times during the Congress.
The colours of the name badge have the following
significance:
Delegate
Accompanying person
Press
Exhibitor
Staff
Blue
Orange
Yellow
Green
Red
TECHNICAL EXHIBITION
A major technical exhibition will take place in the
Exhibition Hall of the Bella Center. For further information, please see page 54.
Opening hours:
Monday,
5 December 2005 09.00 – 17.30 h
Tuesday,
6 December 2005 09.00 – 17.30 h
Wednesday, 7 December 2005 09.00 – 13.00 h
POSTER EXHIBITION
The moderated posters will be located in Hall A3 where
all moderated poster sessions will take place.
The unmoderated posters will be sited next to the
Exhibition Hall, please see as well page 7.
All moderated and unmoderated posters will be displayed during the whole conference. They will be
arranged according to topics and will be numbered
within topics. The poster exhibition is open to all
participants:
Monday
5 December 2005
Tuesday
6 December 2005
Wednesday 7 December 2005
09.00 – 17.30 h
09.00 – 17.30 h
09.00 – 13.00 h
Interested participants can meet the authors for discussion of their posters during following time:
Monday, 5 December 2005: 15.00 - 15.30 h
Tuesday, 6 December 2005: 15.00 - 15.30 h
9
GENERAL INFORMATION
POSTER CD ROM
A CD Rom including all poster presentations will be
produced and all delegates will receive the Poster CD
Rom by post after the congress.
Poster authors are asked to upload the final version
of their poster for the 2005 ESSM Congress Poster
CD Rom in the Speakers Centre. Please bring your
poster in digital form with you to the Speakers
Centre.
COFFEE BREAKS
Coffee and tea are served during the morning and
afternoon coffee breaks from Monday, 5 December
to Wednesday, 7 December 2005 free of charge to
all participants wearing congress name badges. The
coffee station bar is located in the Exhibition Hall of
the Bella Center.
CLOAKROOM
INTERNET CENTRE
Several internet terminals are available to all delegates at the Exhibition Hall of the Bella Center. The internet centre is accessible according to the opening
hours of the exhibition.
A cloakroom is available next to the Registration
Counter. You can also store your luggage here.
BANK
An ATM/cash machine is located in the entrance
foyer (west entrance) of the Bella Center.
PRESS
The press centre is set up in room 16 on the first floor
of the Bella Center. It is open from Monday,
5 December through Wednesday, 7 December 2005.
The press centre is managed by the press agency
Geelmuyden.Kiese.
CURRENCY
The Danish Crown is the official currency in
Denmark. Exchange of foreign currency is available
at the Copenhagen Airport and at most hotels, banks
and exchange offices throughout the city. Most of the
large stores accept Euros.
MESSAGES
A message board will be available at the registration
area of the congress.
RESTAURANTS
Beverages, sandwiches, cakes and light dishes can
be purchased from the self service restaurants, which
are: Buffet Bel next to the exhibtion area on the same
floor and Bella Vista on the first floor, next to the hospitality suites, accessible via a staircase from the exhibition area. Both restaurants accept Euros and credit
cards.
If you will visit a Luncheon Satellite Symposium a
lunchbox will be offered to you by the organizer of
the Satellite Symposium.
ELECTRICITY
Denmark uses a 220 volt 50Hz system. Sockets have
the European standard and plugs are two-prong
grounded.
LOST AND FOUND
A lost and found service is available at the Bella
Center Information in the entrance foyer of the Bella
Center.
MOBILE PHONES
Participants are kindly requested to keep their mobile
phones turned off while attending the scientific
sessions in the meeting rooms.
10
GENERAL INFORMATION
PROGRAM CHANGES
The organisers cannot assume liability for any
changes in the congress program due to external or
unforseen circumstances.
TAXIS
Taxis are available upon demand in front of the west
entrance of the Bella Center. Participants can also
call taxis at the Bella Center Information in the
entrance foyer. Most of the taxis accept credit cards.
INSURANCE
When registering for ESSM 2005 participants agree
that neither the Organising Committee Congress
Secretariat assumes any liability whatsoever.
Participants are highly recommended to make their
own arrangements for health and travel insurance
before they depart from their country. The organisers
will not be responsible for a loss or damage of personal belongings.
PUBLIC TRANSPORTATION PASS
All registered ESSM delegates and accompanying
persons will receive a Travel Pass together with the
personal congress documents at the registration counter. The public transportation pass is valid from
Sunday, 4 December until Wednesday, 7 December
2005 on all buses, trains and metro. The Travel Pass
covers the city of Copenhagen including the Bella
Center and the international airport.
HOSPITALITY SUITES
The major sponsor Pfizer Inc. has arranged a hospitality suite. Please follow the signage in the Exhibition
Hall, the hospitality suite is located in room
Bella Vista 2 on the first floor next to the Bella Vista
restaurant.
AIRPORT
Copenhagen Airport is located 8 km from the city.
Buses, trains and taxis provide transport to the
Copenhagen city center. Taxis can be hired from outside all arrival areas. Fares include VAT and tips and
can normally be paid by credit card. Train tickets are
available from the ticket office above the railway station in Terminal 3.
CAR PARK
Parking space is available next to the Bella Center
and participants arriving by car are advised to use
these facilities. Parking fees are not included in the
registration fee.
11
SOCIAL EVENTS/
SUPPORTING PROGRAM
shops characterize the popular Tivoli’s Christmas
Market atmosphere.
OPENING CEREMONY
Sunday, 4 December 2005
Hall A1 in the Bella Center
18.00 h
The Opening Ceremony will be held in the
Bella Center in Hall A1. The welcome speeches will
be accompanied by typical Scandinavian Christmas
entertainment.
At the end of the Opening Ceremony all participants
are invited to a Welcome Reception at the Entrance
Foyer of the Bella Center where beverages and
snacks will be provided.
ESSM GALA DINNER 2005
and Anniversary Celebration
Tuesday, 6 December 2005
Tivoli Gardens and
Nimb Restaurant at Tivoli Gardens
Vesterbrogarde 3, Copenhagen
Opposite the Main Station
The 8th ESSM gala Event and Anniversary
Celebration will end with the impressive and colourful Water Illuminations on the Lake of the Tivoli
Gardens.
The tickets for this evening will be distributed by the
major sponsors of the congress or can be purchased
at the registration counter on an individual basis.
Please visit the exhibition booths to get your ticket for
this evening.
19.00 h
Dress Code: Casual
‘Wonderful Copenhagen’, Tivoli
Tivoli, the famous
Amusement Park in
Copenhagen, serves
up amusement in
more
traditional
forms. Christmas in
Tivoli is famous for its
romantic and mysterious atmosphere,
charm and spirit.
Join the Christmas
Feeling in Tivoli
Gardens, where the
French illuminations
artist Stef Grivelet
Christmas at Tivoli Gardens
has created a bigger
range of illuminations than ever before. The enchanting Tivoli Lights,
invented by Tiffany’s head designer, John Loring, are
a story in their own right: 1.800 light chains are needed for the trees around the Tivoli Lake.
Before the Gala Dinner you are kindly invited to join
the Tivoli amusements, a few of them are especially
created with a Christmas theme. Nicely decorated
12
After your personal experience in the Amusement
Park, the Nimb Restaurant in the Tivoli Gardens welcomes you to join the ESSM Gala Dinner starting with
a hot Welcome Drink. A typical Danish Christmas
buffet will be served with all its delicious regional dishes and beverages. Light dinner entertainment and a
walk act of the Hans Christian Anderson show - the
famous Danish fairy-tale writer - frames the Gala
Event.
MONDAY, 5 DECEMBER 2005
Copenhagen Sightseeing Tour
14.00 - 17.00 h
The sightseeing tour will bring the participants
through the old and beautiful parts of the capital of
the world’s oldest kingdom whilst the city is nicely
decorated and illuminated during Christmas time.
Amalienborg Palaces - the Queen’s official winter
residence – is one of the sights with the Christian
VIII’s Palace.
Another famous sight is the exquisite Rosenborg
Castle built by Christian IV in 1610, with the crown
regalia and the famous Rosenborg Tapesties, woven
especially for the banquet room of the castle in the
late 1600’s. The tour will also pass The Little
Mermaid and Nyhavn with its cosy restaurants and
the beautiful canal and the magnificent new
Copenhagen Opera House.
Price per person: EUR 47,00
For tickets please contact the registration counter.
EDITOR:
Allen D. Seftel, MD
Professor of Urology
Case Western Reserve University
School of Medicine
Cleveland, Ohio
ADDRESSING SEXUAL MEDICINE FOR BOTH GENDERS.
www.ijir.com
An international, multidisciplinary, academic and clinical publication dedicated to male and female
sexual health.
With a 2004 impact factor of: 1.987*,
International Journal of Impotence Research:
The Journal of Sexual Medicine currently ranks
in the top twenty of all journals in the ISI
category of urology and nephrology. The journal
addresses sexual medicine for both genders as an
interdisciplinary field for a wide audience including
researchers, family practitioners, gynecologists,
internists, psychologists, neurologists, psychiatrists,
endocrinologists, radiologists, urologists and other
health care clinicians.
Topics include
• Male and female sexual dysfunction
• Clinical research including the design and
methodology of clinical trials
• Treatment with a primary care perspective
• Peyronie’s Disease, diabetes mellitus, chronic
renal failure, spinal cord injury, blunt trauma
Visit www.ijir.com to view the journal’s extensive
online features, including:
• Advance Online Publication (AOP) – view
the most recent information available. Papers
available online before they appear in print
• Online Submission – submit papers quickly and
easily with eJournalPress online submission
• Free online content – view the full text of
selected articles
• Full-text HTML references with links to the
corresponding MEDLINE abstracts
• Searches by author name, title or keyword
across Nature and all other NPG titles
• Fully searchable online archive of all issues
from 1997 onwards
For more information visit: www.ijir.com
*Thomson-ISI, USA, PA 2005
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM |
JOURNAL OF EXPOSURE ANALYSIS AND ENVIRONMENTAL EPIDEMIOLOGY | JOURNAL OF PERINATOLOGY | LABORATORY
INVESTIGATION | LEUKEMIA | MODERN PATHOLOGY | MOLECULAR PSYCHIATRY | MOLECULAR SYSTEMS BIOLOGY |
NEUROPSYCHOPHARMACOLOGY | ONCOGENE | PROSTATE CANCER AND PROSTATIC DISEASES | SPINAL CORD | THE
PHARMACOGENOMICS JOURNAL | BONE MARROW TRANSPLANTATION | BRITISH JOURNAL OF CANCER | BRITISH JOURNAL
OF PHARMACOLOGY | CANCER GENE THERAPY | CELL DEATH & DIFFERENTIATION | THE EMBO JOURNAL | EMBO REPORTS |
EUROPEAN JOURNAL OF CLINICAL NUTRITION | EUROPEAN JOURNAL OF HUMAN GENETICS | EYE | GENES AND IMMUNITY |
GENE THERAPY | HEREDITY | INTERNATIONAL JOURNAL OF OBESITY
INTRODUCTION TO THE
SCIENTIFIC PROGRAM
STRUCTURE OF THE SCIENTIFIC PROGRAM
STRUCTURE OF THE ABSTRACT BOOK
The scientific program is structured according to
days. Per day it is structured by time and room.
All presenters are listed by name and the title of
their presentation.
The abstract book is structured by session format.
The listing starts with the Video Session followed
by the Podium and Moderated Poster Sessions.
Hereafter the unmoderated posters are listed
according to topics.
MASTER LECTURES
INSTRUCTIONAL COURSES
Each lecture of 30 minutes will be given by a distinguished and honorable expert and will be devoted to
a specific topic of major interest.
ROUND TABLES
These sessions will usually last 90 minutes. They will
focus on a particular topic and present the very
recent data related to it. The round table will include
a maximum of four papers and time for discussion.
INTERACTIVE SESSIONS
These sessions will last 90 minutes and present case
discussions with a questioner and a panel of
experts. Attendees will be given the possibility to
interact actively via a voting system with the faculty of
the session.
DEBATES
Debates last for 60 minutes and are designed to
cover controversial issues of a particular topic. The
moderator will allow a short introduction for each
topic by the respective opponents followed by a
discussion on the arguments proposed. Comments,
arguments, and questions from the floor are
welcomed during the discussion.
These 90 minutes lasting sessions present detailed material on a chosen topic. Courses are designed to emphasize learning experiences that actively involve participants and include an opportunity for informal exchange
with the faculty.
POST GRADUATE COURSES
The postgraduate courses last for 90 minutes.
Courses are designed to present advanced materials
on a specific topic. In addition, the latest scientific
progress will be reviewed and evaluated in a format
that actively involves the participants, and includes
opportunities for discussions and informal interaction
with the faculty.
PODIUM SESSIONS
Podium Sessions will present the best quality papers
accepted for the Congress by the Scientific Committee that will focus on special topics presenting the
very recent findings in this field. Each session will last
90 minutes and are intended to 10 talks per session.
Each presentation is limited to 7 minutes followed by
3 minutes of discussion.
MODERATED POSTER SESSIONS
POINT-COUNTERPOINT SESSIONS
These sessions are organized to address one controversial issue of a topic. The moderator will allow a
brief introduction for each topic by the respective
opponents followed by a discussion on the arguments
proposed.
14
Authors are invited to present their new research findings or important ongoing research as posters. The
most interesting ones will be combined by topics and
moderated in a 90 minutes lasting session. Each
session consists of a maximum of 15 talks of the same
field. Each presentation is limited to 4 minutes followed by 2 minutes of discussion.
INTRODUCTION TO THE
SCIENTIFIC PROGRAM
SYMPOSIA ORGANIZED BY THE INDUSTRY
Symposia organized by the Industry
Symposia organized by the Industry in consultation
with the Scientific Committee will be presented at the
afternoon on Sunday, 4 December 2005 before the
Opening Ceremony as well as on Monday, 5 and
Tuesday, 6 December 2005.
Luncheon Symposia organized by the Industry
Symposia organized by the Industry in consultation
with the Scientific Committee will be presented at the
lunch time on Monday, 5 December and Tuesday, 6
December 2005. Participants will be provided with a
lunchbox at the beginning of the symposium.
CME (CONTINUING MEDICAL EDUCATION)
This Congress has been submitted for UEMS accreditation to the European Accreditation Council for
Continuing
Medical
Education
(EACCME).
Physicians will be accredited with 15 CME credits for
the whole period of the congress.
EACCME credits are recognized by the American
Medical Association towards Physician's Recognition
Award (PRA).
To convert EACCME credit to AMA PRA category
1 credit, contact the AMA.
You will find the UEMS evaluation forms in your
personal documents. Please fill them in and leave
them at the ESSM booth in the exhibition area at the
end of the Congress. The ESSM Secretariat will send
the certificate after the Congress.
MEETING AWARDS
The best preclinical and clinical presentations will be
awarded with EUR 2.000 by ESSM’s Award Committees.
1. Prize for the best presentation on FSD (preclinical)
2. Prize for the best presentation on FSD (clinical)
3. Prize for the best presentation on MSD (preclinical)
4. Prize for the best presentation on MSD (clinical)
5. Prize for the best surgical presentation
The ESSM Prestigious Awards
The Executive Committee of ESSM has established
two awards to be presented during the annual meetings of the society.
n The ESSM Career Award
for distinguished contribution in Sexual Medicine
This award will be given to a senior scientist with
outstanding contribution in the field. The
Executive Committee has made the decision and
the award will be presented during the Opening
Ceremony.
n The ESSM Award of Excellence
for exceptional achievements in Sexual Medicine
Research
This award is given annually to a young
scientist with exceptional achievements in the
field. Eligable applicants are scientists under the
age of 40 with significant contribution to the field.
This year a prize will be given separately in basic
and clinical research.
This Congress has been submitted for CME accreditation to the Italian Ministry of Health. Physicians will
be accredited. You will find the ECM evaluation
forms in your personal documents. Italian delegates
are asked to fill them in and leave them at the ESSM
booth in the exhibition area at the end of the
Congress. The ESSM Secretariat will send the
certificate after the Congress.
15
SCIENTIFIC PROGRAM
ML - MASTER LECTURE
R - ROUND TABLE
IS - INTERACTIVE SESSION
D - DEBATE
CP - POINT-COUNTERPOINT SESSION
C - INSTRUCTIONAL COURSE
PG - POSTGRADUATE COURSE
PS - PODIUM SESSION
MP - MODERATED POSTER SESSION
S - SATELLITE/LUNCHEON SYMPOSIUM
P - POSTER PRESENTATIONS
16
PROGRAM SCHEDULE
SUNDAY, 4 DECEMBER 2005
Room
Hall A1
Auditorium
Various Meeting Rooms
Entrance Foyer
Time
08.00 −
08.30 09.00 −
09.30 10.00 −
10.30 -
Meetings of Affiliated Societies
08.00 - 19.30 h
Registration
in the
Entrance Foyer
11.00 −
11.30 12.00 −
12.30 -
V-1
13.00 −
Video Surgery
Course
13.30 14.00 −
14.30 15.00 −
15.30 16.00 −
D-1
16.30 - The Journal of Sexual
Medicine Debate
17.00 −
17.30 18.00 −
S-1
A Discourse on Intercourse:
Viagra Hard Erections. Improved Sexual Satisfaction
18.30 - Opening Ceremony
and
19.00 − Welcome Reception
19.30 20.00 −
20.30 21.00 −
21.30 -
Individual Dinner Invitations
22.00 −
22.30 23.00 −
17
PROGRAM SCHEDULE
Room
Hall A1
Hall A2
Hall A3
Auditorium
Time
08.00 −
08.30 09.00 −
09.30 -
Premature Ejaculation: from
Links between Depression
ML-2 and Sexual Dysfunction
the Lab to the Clinic: AdML-3 From
vances in Erectile Dysfunction
COFFEE
10.30 - IS-1
Erectile Dysfunction
11.00 − Management
11.30 12.00 −
07.00 - 19.30 h
Registration
in the
Entrance Foyer
ML-1 brain to mind/body interface
10.00 −
ML-4
BREAK
MP-1
General Issues in
Sexual Medicine
PS-1
Basic Science
C-1
Basics in Ejaculatory
Disorders
ESSM Award Lecture
Basic Science
BREAK
12.30 -
S-2
13.00 −
ED & Beyond-Lessons to Learn
from the Past for the Future
13.30 R-1
Future Pharmacological
14.30 - Options to treat Female
Sexual Disorders
15.00 −
14.00 −
15.30 16.00 −
16.30 -
MP-2
Surgery
PS-2
Pharmacology
COFFEE
R-2
Hot Topics with
PDE5 Inhibitors
C-2
Erectile Dysfunction:
The Basics
BREAK
PS-3
Ejaculatory Disorders
17.00 −
C-3
Basics of Female
Sexual Function and
Dysfunction
S-3
17.30 - Premature Ejaculation:
18.00 − Patients, Partners,
Preconceptions, Promise
18.30 19.00 −
Annual ESSM
Business Meeting
19.30 20.00 −
20.30 21.00 −
21.30 22.00 −
22.30 23.00 −
18
Hall E1
Entrance Foyer
Individual Dinner Invitations
09.00 - 17.30 h
Technical Exhibition
in Hall E1
PROGRAM SCHEDULE
TUESDAY, 6 DECEMBER 2005
Room
Hall A1
Hall A2
Hall A3
Auditorium
Time
08.00 −
08.30 09.00 −
09.30 -
ML-6
ESSM Award Lecture
Clinical
Neurobiology of
Female Desire
ML-7
The Ageing Woman
ML-5
07.30 - 18.00 h
Registration
in the
Entrance Foyer
COFFEE
10.00 −
IS-2
10.30 - Female Sexual Disorders - PS-4
11.00 − Diagnosis and Manage- Surgery
ment
11.30 CP-1 Pros & Cons for
Penile Augmentation
12.00 −
12.30 13.00 −
13.30 -
09.00 - 17.30 h
in Hall E1
BREAK
HS-1
ESSM History Session PS-5
Therapy and EDCP-2 Gene
Exp. Tool/Treatment
COFFEE
15.30 -
R-3
The Metabolic Syndrome
and Erectile Dysfunction
16.00 −
16.30 -
18.00 −
C-4
PG-1
Androgen Supplementation Erectile Dysfunction in Men - Basics
A One-Year-Update
New Perspectives in
ED Management - Regaining
Couples Satisfaction
15.00 −
17.30 -
BREAK
S-4
14.00 − IS-3
14.30 - Ejaculatory Disorders
17.00 −
Hall E1
Entrance Foyer
C-5
Penile Surgery: Basics
BREAK
MP-3
Pharmacology
C-6
Priapism
S-5
The Rationale for Testosterone
Therapy in Erectile Dysfunction
18.30 19.00 −
19.30 20.00 −
20.30 21.00 −
21.30 -
ESSM Gala Dinner 2005
Anniversary Celebration
at Tivoli Gardens
22.00 −
22.30 23.00 −
19
PROGRAM SCHEDULE
WEDNESDAY, 7 DECEMBER 2005
Room
Hall A1
Hall A2
Hall A3
Auditorium
Time
08.00 −
08.30 - R-4
CNS Pharmacology and
09.00 − Erectile Dysfunction
09.30 -
COFFEE
10.00 −
10.30 -
PS-6
Hormones and Sexuality
MP-4
BREAK
09.00 - 13.00 h
in Hall E1
11.00 −
12.30 13.00 −
07.30 - 13.00 h
C-7
Registration
Treatment for the Nonin the
Responder to Oral Therapy Entrance Foyer
D-2
Rapid Ejaculation
11.30 - IS-4
12.00 − Peyronies Disease
Hall E1
Entrance Foyer
PS-7
Epidemiology and
Risk Factors
MP-5
Basic Science
C-8
Sexual Counselling and
Therapeutic Approaches
for Non-Experts
Closing Remarks
We are looking forward to welcoming you to
Vienna 2006
9th ESSM Congress
3 - 6 December 2006
Vienna, Hofburg
20
SCIENTIFIC PROGRAM
SUNDAY, 4 DECEMBER 2005
VIDEO SURGERY COURSE
V-1
12.00 - 16.00 h
Auditorium 15
Video Surgery Course
Chairs:
Fulvio Colombo, Italy
Ates Kadiouglu, Turkey
V-1-006
Correcting penopubic epispadias without
incontinence: Our experience
Chiara Stefania Guerrer, Italy
F. Colombo, C. S. A. Guarneri,
A. L. Romano, V. Inneo, E. Austoni
V-1-001
Medial dissection of the neurovascular bundle
in Peyronie's patients with dorsal curvature:
Demonstration of a technique and analysis of
outcome
Tolga Akman, Turkey
O. Sanli, L. Gurkan, M. Cakan,
M. Tezer, A. Kadioglu
V-1-007
Hypospadias. Mathieu repair and use of
dartos flap
Aristomenis Gekas, Greece
P. Kartsaklis, I. Palaiodimos,
C. Konstantinidis, A. Papatsoris,
N. Kalogeropoulos, M. Djordjevic,
S. Perovic
V-1-002
Use of rectus fascia graft for corporeal reconstruction during implantation of penile prosthesis in Peyronie's disease
Tolga Akman, Turkey
O. Sanli, L. Gurkan, M. Cakan,
K. Onem, A. Kadioglu
V-1-008
Penile carcinoma - organ sparing surgery
Sava Perovic, Bosnia and Herzegovina
M. Djordjevic
V-1-009
Penis lengthening with girth enhancement:
The surgical technique seen from the "inside"
together with human cadaver detail anatomical presentation
Vasileios Protogerou, Greece
P. Tekerlekis, P. Dretas,
S. Anagnostopoulou, A. Kostakopoulos,
K. Konstantinidis
V-1-010
Erectile tissue sparing penile prosthesis
implantation
G. Pedemonte,
J. I. Martinez-Salamanca,
C. Hernandez, M. Moralejo
V-1-003
Surgical treatment of Peyronie disease using
ecxision of the plaque
Kazimierz Krajka, Poland
M. Matuszewski, W. Moszczynski
V-1-004
Nesbit straightening corporoplasty, guided by
dynamic pharmacoinfusion alternated with
saline solution infusion
F. Colombo, C. A. Guarneri,
E. Austoni, J. Piedra Aguilera,
A. L. Romanò
V-1-005
Congenital penile curvature
John Vlachiotis, Greece
A. Grigorakis, D. Petsis, J. Gialas,
G. Tsibukis, K. Spiliopoulos, A. Tsidavis
DEBATE
D-1
16.00 - 17.00 h
Hall A1
The Journal of Sexual Medicine Debate: The man's erectile performance is influenced in part by the woman's sexual function
Chair:
Irwin Goldstein, United States
ProAuthors:
ConAuthors:
Sigfried Meryn, Austria
Axel Fugl-Meyer, Sweden
SATELLITE SYMPOSIUM
S-1
17.00 - 18.00 h
Auditorium 15
A Discourse on Intercourse: Viagra® (Sildenafil Citrate)
Hard Erections. Improved Sexual Satisfaction
Chair:
Klaus-Peter Juenemann, Germany
S-1-001
Chairman's Opening Remarks
S-1-002
NO, O2, and PDE5: The Scientific Language of Sex
S-1-003
From Science to Physiology: Viagra® Delivers
Hard Erections
S-1-004
Delivering Patient and Partner Satisfaction
Rosie King, Australia
S-1-005
Questions and Answers / Closing Remarks
sponsored by an educational grant
from Pfizer Inc.
21
SCIENTIFIC PROGRAM
MASTER LECTURE
08.00 - 08.30 h
ISSM Lecture
Chair:
ML-1-001
08.30 - 09.00 h
Chair:
ML-2
Hall A1
Links between Depression and Sexual
Dysfunction
Uwe Hartmann, Germany
MASTER LECTURE
09.00 - 09.30 h
ESAU Lecture
Chair:
John Pryor, United Kingdom
ML-3-001
Hall A1
Premature Ejaculation: from the brain to the
mind/body interface
David Rowland, United States
MASTER LECTURE
ML-2-001
ML-1
ML-3
Hall A1
From the Lab to the Clinic: Advances in Erectile
Dysfunction
Vincenzo Mirone, Italy
09.30 - 10.00 h COFFEE BREAK
INTERACTIVE SESSION
10.00 - 11.30 h
Erectile Dysfunction Management
Chair:
Siegfried Meryn, Austria
Panel:
22
Beatrice Cuzin, France
J. Oldbring, Sweden
Edoardo S. Pescatori, Italy
Claude Schulman, Belgium
Little Mermaid
IS-1
Hall A1
INSTRUCTIONAL COURSE
C-1
10.00 - 11.30 h
Auditorium 15
Basics in Ejaculatory Disorders
Chair:
Marcel D. Waldinger, The Netherlands
C-1-01
Symptoms, classification and definitions
C-1-02
Epidemiology and Diagnosis
Axel Fugl-Meyer, Sweden
C-1-03
Non-Pharmacological Treatments
C-1-04
Pharmacological treatment options evidence-based vs opinion-based approaches
SCIENTIFIC PROGRAM
PODIUM SESSION
10.00 - 11.30 h
Basic Science
Chairs:
Mustafa Faruk Usta, Turkey
PS-1-001
PS-1
Hall A2
C-type Natriuretic peptide is an endotheliumderived hyperpolarizing factor in human penile
resistance arteries
A. Kun, Hungary
I. Kiraly, I. Krassoi, Z. Marton,
J. Pataricza, L. Pajor, U. Simonsen
A. Varro, J. G. Papp
PS-1-002
Characteristics of Phosphate-1-Sphingosin
Receptors in human corpus cavermosum:
Cross-talk with eNOS and caveoline-1
F. Fusco, C. Imbimbo, R. Ranavolo,
R. Buonopane, G. Cirino,
R. d'Emmanuele di Villa Bianca
PS-1-003
Phosphate-1-sphingosin aims Achetilcolin
mediated relaxation activating the eNOS in
Human Corpus Cavernosum Stripes
P. Verze, A. Palmieri, N. Longo,
A. M. Granata, G. Cirino,
R. d'Emmanuele di Villa Bianca
PS-1-004
PS-1-005
Dysregulation of cgmp-dependent protein kinase-1 (pkg1) impairs erectile function in diabetic
rats: Influence of in vivo gene therapy of
pkg1a
Trinity J. Bivalacqua, United Kingdom
M. Kendrici, W. Hellstrom,
K.-E. Andersson, H. C. Champion,
P. Hedlund
Effect of combination of alt-711 an age
(advanced glycation end product) cross-link
breaker and sildenafil on erectile function in
stz-diabetic rats
A. Sanli, G. Sagdic, A. Baykal,
N. Gurbuz
PS-1-006
Calcium-activated potassium channel openers
potentiate PDE5 inhibitor-induced relaxations in
human penile arteries and augment PDE5-inhibitor effects on erectile responses in diabetic
rats
P. Cuevas, S. Gabancho, J. M. Pomerol,
E. Ruiz-Castane, A. Puigvert, I. Saenz
de Tejada, R. Gonzalez-Corrochano
PS-1-007
Role of endothelin-1 in the migration of human
olfactory gonadotropin-releasing
hormone-secreting neuroblasts
Annamaria Morelli, Italy
R. G. Romanelli, T. Barni, M. Luconi,
P. Failli, A. Pezzatini, R. Maggi,
L. Vignozzi, R. Salerno, S. Ambrosini,
M. Marini, F. Lotti, G. B. Vannelli,
M. Maggi
PS-1-008
Rho kinase is involved in both calcium entry
and calcium sensitization of rat penile arteries
Dolores Prieto, Spain
E. Stankevicius, N. Villalba, A. GarciaSacristan, U. Simonsen
PS-1-009
Small molecule inhibitor of transforming growth
factor-ß type I Receptor: A new candidate for
the treatment of erectile dysfunction and
cavernous fibrosis
Jun-Kyu Suh, Republic of Korea
S.-M. Oh, J.-K. Ryu, H.-Y. Shin,
S. U. Song, L. Zhang, S. Piao
PS-1-010
Mechanism for erectile dysfunction in a rat
model of binge cocaine use
Muammer Kendirci, United States
L. Pradham, L. Trost, K. Agarwal,
W. J. G. Hellstrom
23
SCIENTIFIC PROGRAM
MODERATED POSTER SESSION
10.00 - 11.30 h
Hall A3
General Issues in Sexual Medicine
Chairs:
Daniel Richardson, United Kingdom
MP-1-071
MP-1-072
Preoperative psychometric parameters in
patients with prostate cancer and candidates
to radical prostatectomy
A. Gallina, U. Capitanio, A. Sacca,
S. Clerici, E. Farina, F. Deho,
E. Longhi, P. Rigatti, F. Montorsi,
G. Zanni
MP-1-079
Increased waist circumference and dyslipidemia
as an indicator of erectile dysfunction
Omer Demir, Turkey
M. Oder, N. Unlu, C. T. Karatas,
O. Demir, E. Can, K. Ozer,
O. M. Sahin, B. H. Gumus,
A. Esen, K. Bal
MP-1-080
Contribution of sex to partnership and selfesteem in different types of men
Michael Berner, Germany
M. Burkart
MP-1-081
Penile venous leakage in hypogonadism:
Recovery of venous leakage and changes in
cavernosal hymodynamic under long-acting
testosterone 1000mg i.m.
Aksam Yassin, Germany
MP-1-082
Are consecutive nights RigiScan recording required for optimal evaluation of sleep associated
erections?
Juza Chen, Israel
N. Mabjeesh, G. Keren-Paz, M. Sofer,
H. Matzkin, A. Greenstein
MP-1-073
Alexithymia in patients with Premature
Ejaculation (PE)
P. M. Michetti, D. Bonanno, P. de
Martino, C. de Dominicis, R. Rossi
MP-1-074
Actions of dapoxetine on ejaculation and sexual
behaviour in rats
Peter Gengo, United States
L. Marson, K. Gravitt
MP-1-083
Penile shortening after radical prostatectomy
(RP): Cavernous fibrosis or urethral shortening?
Paolo Gontero, Italy
M. Galzerano, F. Fontana, F. Sogni,
E. Kocjancic, G. Pretti, B. Frea,
N. Mondaini
Development of the Sexual Experience
Questionnaire (SEX-Q)
J. Harnett, K. Hvidsten, S. Kennedy,
L. Leroy, P. Reddy
MP-1-084
Is androgen replacement therapy for hypogonadal men in the form of a transdermal gel
(Testogel) acceptable to patients attending a
Men's Sexual Health Clinic, compared with
older applications?
John Tomlinson, United Kingdom
H. Raphael, R. Mehta
MP-1-085
Recommendations for the management of premature ejaculation of the British Association of
Sexual Health and HIV special interest group in
sexual dysfunction
D. Goldmeier, J. Green, H. Lamba,
J. W. Harris
MP-1-075
MP-1-076
24
The role of telephone helplines for sexual
problems: Portugal's six years experience
Patricia Pascoal, Portugal
N. Monteiro Pereira
MP-1
Premature ejaculation in heterosexual couples:
The psycosexuological perceptions of men's
ejaculatory behavior
Elena Longhi, Italy
P. Rigatti, F. Montorsi, A. Salonia
MP-1-077
Recommendations for the management of
retarded ejaculation of the British Association
of Sexual Health and HIV special interest group
in sexual dysfunction
D. Goldmeier
MP-1-078
Should routine serum cholesterol and triglycerides be part of assessment for ED?
Sak Sei Chung, United Kingdom
A. Storey, L. Burr, P. Tirukonda,
I. Eardley, O. Baldo
SCIENTIFIC PROGRAM
MASTER LECTURE
11.30 - 12.00 h
ESSM Award Lecture - Basic Science
Chair
ML-4-001
ML-4
Hall A1
Male and female genital responses - Vascular
function in health and disease
12.00 - 12.30 h BREAK
LINCHEON SATELLITE SYMPOSIUM
S-2
S-2-001
Welcome and Opening Remarks
S-2-002
What Drives Treatment Choice ?
S-2-003
On-Demand Dosing for a Chronic Condition ?
Sidney Glina, Brazil
S-2-004
Beyond ED: Are There Other Vascular Benefits
with PDE5 Inhibitor Therapy ?
S-2-005
Questions and Closing Remarks
‘Wonderful Copenhagen’
12.30 - 13.30 h
Auditorium 15
ED and Beyond - Lessons to Learn from the Past for the Future
Chair:
Slotholmen - Christianborg Palace
from Lilly ICOS
ROUND TABLE
R-1
C-2
13.30 - 15.00 h
Hall A1
Future Pharmacological Options to treat Female Sexual
Disorders
Chair:
Yoram Vardi, Israel
13.30 - 15.00 h
Auditorium 15
Erectile Dysfunction: The Basics
Chairs:
R-1-01
Is there a role for testosterone-therapy in
female sexual medicine?
C-2-01
Anatomy and Physiology
Ferdinando Fusco, Italy
R-1-02
Centrally active agents and female sexual
responses
C-2-02
History and physical examination
Bert-Jan de Boer, The Netherlands
C-2-03
Patient Investigation
C-2-04
Treatment
R-1-03
Vasoactive agents and female sexual arousal
disorders
Yoram Vardi, Israel
25
SCIENTIFIC PROGRAM
PODIUM SESSION
Hall A2
PS-2-016
Why do PDE-5 inhibitors patients lapse from
follow-up? Results of a pilot study
Giorgio Pomara, Italy
S. Simi, G. Morelli, P. Turchi
PS-2-011
Open label, multicenter, crossover study of
sildenafil citrate and tadalafil for the treatment
of erectile dysfunction in patients naive to
phosphodiesterase 5 inhibitor therapy
F. Montorsi, D. Ralph, P. Kell, Y. Zhao,
L. M. Harrison, A. Beardsworth,
V. Mirone
PS-2-017
Long term sildenafil administration improves
aortic stiffness and wave reflections in patients
with erectile dysfunction of vascular origin
Charalambos Vlachopoulos, Greece
N. Ioakeimidis, K. Rokkas,
K. Aznaouridis, P. Xaplanteris,
G. Siasos, A. Askitis, C. Stefanadis
PS-2-012
Efficacy and tolerability of flexible-dose vardenafil when taken 8 hours before intercourse:
The extended duration of vardenafil in erectile
dysfunction (extend) trial
I. Sharlip, D. Hatzichristou, E. RubioAurioles, M. Gittleman, B. N. Stancil,
H. J. Wilkins, P. Pommerville for the
Vardenafil Study Group
PS-2-018
Efficacy of phosphodiesterase type 5 inhibition
in severely affected erectile dysfunction
patients with an erectile function domain score
of five
Philip Kell, United Kingdom
O. Collins, J. Dean, D. Edwards,
D. Ralph, I. Eardley
PS-2-019
A double-blind, randomized, placebo-controlled
cross-over study on the effects of testosterone
(testogel) plus sildenafil on cavernous arteries
and psychological correlates in men with mild
hypogonadism and erectile dysfunction
V. Fierro, F. Malizia, E. A. Greco,
D. Canale, E. Macchia, A. M. Isidori,
V. Bonifacio, D. Gianfrilli, E. A. Jannini,
G. Spera, A. Lenzi, A. Fabbri,
A. Fabbri, A. Lenzi, G. Spera,
C. Moschina, C. Cagliaresi
PS-2-020
Tadalafil 5 mg and 10 mg taken once a day for
the treatment of erectile dysfunction improves
patient sexual satisfaction
Jacques Buvat, France
G. Faria, U. Wetterauer, A. von Keitz,
W. Dinsmore, W. C. Wang,
D. Stothard, W. Cordell
13.30 - 15.00 h
Pharmacology
Chairs:
Lars Ny, Sweden
26
PS-2
PS-2-013
Efficacy of udenafil for the treatment of erectile
dysfunction up to 12 hours after dosing:
A randomized controlled trial
N.C. Park, Republic of Korea
K. S. Min, K. Park, J. K. Park,
J. S. Paick
PS-2-014
Safety and efficacy of avanafil, a new PDE5
inhibitor for treating erectile dysfunction
Joel Kaufman, United States
J. Dietrich
PS-2-015
The efficacy and safety of tadalafil taken once
a day for up to 1 year for the treatment of
erectile dysfunction
S. Glina, D. Ralph, A. Casabe,
A. Elion-Mboussa, W. Shen,
D. Stothard, J. S. Whitaker, H. Porst
SCIENTIFIC PROGRAM
MP-2
13.30 - 15.00 h
Hall A3
Surgery
Chairs:
Konstantinos Hatzimouratidis, Greece
MP-2-093
Skin grafting for treating Penile Cancer
Giulio Garaffa, United Kingdom
A. Bashir, S. Minhas, D. Ralph,
V. Agrawal
MP-2-086
Use of SELDI to determine whether Peyronie's
Disease Protein Expression can predict
progression
Gerald Brock, Canada
B. Gan, K. B. Lim, L. De Young,
A. Bella
MP-2-094
Surgical management of lymphoedema of the
genitalia
A. Freeman, A. Bashir, S. Minhas,
N. Christopher, D. Ralph, V. Agrawal
MP-2-095
MP-2-087
New in the pathogenesis of Peyronie's Disease
Larisa Ivanchenko, Russia
E. Mazo
MP-2-088
Does diabetes mellitus increase the severity of
peyronie's disease. A comparative clinical study
L. Trost, S. C. Sikka,
W. J. G. Hellstrom
Female-to-Male gender reassignment surgery:
Italian multicentric experience
Fabrizio Palumbo, Italy
F. Palumbo, F. Boezio, P. Ditonno,
E. Austoni, E. Belgrano, V. Mirone,
C. Bettocchi, F. P. Selvaggi
MP-2-096
Male-to-Female gender reassignment surgery:
Italian Multicentric experience
V. Stellacci, F. Palumbo, M. Battaglia,
F. Colombo, C. Trombetta, C. Imbimbo,
C. Bettocchi, F. P. Selvaggi
MP-2-097
Clinical anatomical study: Does release of
ligaments provide real penile lengthening?
Hui Zhu, People's Republic of China
Y. Long, Y. Cui, D. Long, H. Zhou,
G. Li, H. Zhang, S. Perovic, Z. Cai
MP-2-098
Enlargement of the penis using intexen:
A personal technique
Piero Letizia, Italy
G. Alei
MP-2-099
Penile girth augmentation using flaps "shaeer's
augmentation phalloplasty"
Osama Shaeer, Egypt
K. Shaeer
MP-2-100
Comparison of antibacterial activity of inhibizone and antibiotic coated titan implant
Tony John, United States
A. Rajpurkar, C. Dhabuwala
MP-2-089
MP-2-090
MP-2-091
MP-2-092
Results of a standardized survey among
German urologist concerning assessment of
conservative therapy of Peyronie's disease
Ekkehard Hauck, Germany
S. Haag, T. Bschleipfer, V. Rohde,
W. Weidner
Correlation between congenital and acquired
elements in penile curvature and consequent
possible new indications for surgical correction
Ignazio Gattuccio, Italy
F. Montalto, C. Gagliardo, F. Zangara,
M. Parrinello, F. Gattuccio
A comparison of Nesbit's procedure versus
plaque incision and grafting for Peyronie's
Disease
Chi-Ying Li, United Kingdom
V. Agarwal, P. Kell, S. Minhas,
D. Ralph
Total Phallic Reconstruction in management of
Penile Cancer: Experience in 10 patients from a
single centre
Vineet Agrawal, United Kingdom
N. Christopher, S. Minhas, D. Ralph,
O. Kayes
27
SCIENTIFIC PROGRAM
ROUND TABLE
R-2
15.30 - 17.00 h
Hall A2
Hot Topics with PDE5 Inhibitors
Chair:
15.30 - 17.00 h
Auditorium 15
Basics of Female Sexual Function and Dysfunction
Chair:
R-2-01
C-3-01
Physiology and Pathophysiology
C-3-02
Epidemiology and Classifications
C-3-03
Diagnostics
C-3-04
Treatment options
Inside the pharmacology of PDE5 inhibitors onset, durations, side-effects, interactions
and dosing
R-2-02
PDE5 inhibitors and the cardiovascular systemdilemmas and challenges
Piero Montorsi, Italy
R-2-03
Androgens and efficacy of PDE5 inhibitors
Mario Maggi, Italy
R-2-04
Non-responders – Is there a second chance?
Konstantino Hatzimouratidis, Greece
PS-3
PODIUM SESSION
Hall A3
PS-3-025
Prevalence of premature ejaculation among
men with erectile dysfunction in the men's
attitudes to life events and sexuality (MALES)
study
W. A. Fisher, Canada
R. C. Rosen, M. Sand, I. Eardley
Penile sensitivity in patients affected by premature ejaculation: Results of a case-controlled
study
G. Zanni, F. Deho, N. Suardi,
E. Longhi, G. V. Fantini, P. Rigatti,
F. Montorsi, A. Briganti
PS-3-026
Premature ejaculation: Combined intervention
Antonio Fernandez Lozano, Spain
N. Hannaoui, C. Abad Gairin, E. Ruiz
Castañe, A. Fernandez Lozano,
F. Cabello Santamaria
PS-3-027
Pudendal motoneuron reflex discharges in
anesthetized rats are delayed by dapoxetine
P. Gengo, M. Laurin, P. Clement,
J. Bernabe
PS-3-028
Dapoxetine for the treatment of premature
ejaculation: Efficacy and tolerability
Sherron Kell, United States
S. Althof, C. Steidle, M. Miloslavsky,
J. Pryor
PS-3-029
Preliminary study of electric stimulation on premature ejaculation in patients with chronic
pelvic pain syndrome or chronic prostatitis
Wei Yu Lin, Taiwan
PS-3-030
A centrally, but not peripheral, role for
oxytocin in ejaculation?
Chris Wayman, United Kingdom
N. Robinson, J. Gupta, D. Baxter,
R. Ward, M. Jackson, R. Russell
15.30 - 17.00 h
Chairs:
Paul Enzlin, Belgium
PS-3-021
PS-3-022
PS-3-023
PS-3-024
28
C-3
Prevalence and impact of premature ejaculation
and patient treatment goals in a communitybased general medical practice
Matt Rosenberg, United States
C. Tallman, N. Sailor, D. Ohl,
M. Hazzard
Index of premature ejaculation: A new questionnaire to evaluate men's level of control over
ejaculation, satisfaction with sex life, and level
of distress
Tara Symonds, United Kingdom
R. Rosen, K. May, R. Mundayat,
S. Althof
Psycho-biological correlates of delayed ejaculation in male patients with sexual dysfunctions
Giovanni Corona, Italy
L. Petrone, E. Mannucci, G. Forti,
M. Maggi, G. Balercia, A. Fisher,
R. Giommi, A. Pizzocaro, G. de
Scisciolo, M. Maggi, G. Forti, F. Lotti
SCIENTIFIC PROGRAM
SATELLITE SYMPOSIUM
S-3
17.00 - 18.30 h
Hall A1
Premature Ejaculation: Patients, Partners, Preconceptions,
Promise
Chair:
S-3-001
Chairman's Introduction
S-3-002
Evolution of the Understanding of Premature
Ejaculation: Historical Perspectives
Marcel D. Waldinger, Netherlands
S-3-003
Pan-European Perspectives on Premature
Ejaculation
A major technical exhibition welcomes you in the Exhibition Hall.
A coffee bar is integrated in the
exhibition area.
Opening hours
Monday, 5 December 2005
09.00 – 17.30 h
S-3-004
Partners and Relationships: Impact of
Premature Ejaculation
Patricia Barnes, United Kingdom
S-3-005
Revolution in the Treatment of Premature
Ejaculation: A Novel Treatment Approach
09.00 – 17.30 h
S-3-006
Panel Discussion and Concluding Remarks
09.00 – 13.00 h
from Janssen-Cilag
ANNUAL ESSM BUSINESS MEETING
18.30 - 19.30 h
Hall A2
29
SCIENTIFIC PROGRAM
MASTER LECTURE
08.00 - 08.30 h
ESSM Award Lecture - Clinical
Chair:
Novel aspects of Peyronies Disease
Ekkehard Hauck, Germany
MASTER LECTURE
08.30 - 09.00 h
Chair:
ML-6-001
ML-6
Hall A1
Neurobiology of Female Desire
Jim Pfaus, Canada
MASTER LECTURE
09.00 - 09.30 h
Chair:
ML-7-001
Hall A1
ML-7
Hall A1
The Ageing Woman
Alessandra Graziottin, Italy
Amagar Torv
INTERACTIVE SESSION
IS-2
C-4
10.00 - 11.30 h
Hall A1
Female Sexual Disorders - Diagnosis and Management
Chair:
10.00 - 11.30 h
Androgen Supplementation in Men - Basics
Chair:
Panel :
C-4-01
Why bother about androgen deficiency?
C-4-02
The assessment of men with androgen
deficiency symptoms
C-4-03
Initiating androgen therapy
Eric Meuleman, The Netherlands
C-4-04
Ongoing therapy
John Tomlinson, United Kingdom
Brian Daines, United Kingdom
Emmanuele Jannini, Italy
Ruth Hallam Jones, United Kingdom
Llynwen Wilson, United Kingdom
POSTGRADUATE COURSE
PG-1
10.00 - 11.30 h
Auditorium 15
Erectile Dysfunction - A One-Year-Update
Chair:
Speaker:
30
‘Wonderful Copenhagen’, C. van Roeden
ML-5-001
ML-5
Alberto Briganti, Italy
Hall A3
from Ipsen Pharma
SCIENTIFIC PROGRAM
PODIUM SESSION
PS-4
10.00 - 11.30 h
Hall A2
Surgery
Chairs:
PS-4-031
The natural history of Peyronie's Disease: An
ultrasonographic study
M. Arvaniti, V. Tzortzis, A. Apostolidis,
D. Hatzichristou, A. Bekos
PS-4-032
Two year follow-up of plaque incision and
plication to correct Peyronies disease
Hubert I.M. Claes, Belgium
H. Van Poppel
PS-4-033
An analysis of dermal, pericardial and small
intestinal submucosal grafts in the surgical
management of Peyronie's Disease
J. Kovac
PS-4-034
PS-4-035
Long term post-operative satisfaction after
soft prosthesis implantation and plaque surgery
with saphenous grafting for peyronie's disease: A retrospective study
C. S. Guerrer, A. Pistuddi, A. Guarneri,
A. L. Romano, F. Colombo, E. Austoni
One stage repair of iatrogenic trapped penis
Sava Perovic, Bosnia-Herzegovina
M. Djordjevic
PS-4-037
Inflatable Penile Prosthesis (ipp) for organic
impotence. Surgical and functional of 202
surgical procedures through peno-scrotal
approach in the same institution
Jack-Charles Tremeaux, France
PS-4-038
Medium and long term follow-up of penile
prosthesis implant with tunica albuginea
incision in severely fibrotic penis
A. Briganti, G. E. Zanni, N. Suardi,
L. Barbieri, P. Rigatti, F. Montorsi,
F. Deho
PS-4-039
Ischaemic priapism: Acute versus delayed penile
implant insertion results in fewer complications
Pardeep Kumar, United Kingdom
O. Kayes, N. Christopher, D. J. Ralph,
S. Minhas, V. Agrawal
PS-4-040
Pudendus-Reinnervation after penile reconstruction: Sensory-evoked potentials (SEP) in
correlation to subjective questionnaire results
Karsten Wirsam, Germany
M. Sohn, K. Exner, C. Horbach
Use of synthetic biodegradable polymer for corporeal reconstruction during penile reimplantation
Peter Scheplev, Russia
B. Gvasaliya, N. Garin, S. Perovic
POINT-COUNTERPOINT SESSION
11.30 - 12.00 h
Pro and Cons for Penile Augmentation
Chair:
Hans Hedlund, Sweden
ProSpeaker:
ConSpeaker:
PS-4-036
CP-1
Hall A1
Sava Perovic, Serbia
Eric Wespes, Belgium
12.00 - 12.30 h BREAK
31
SCIENTIFIC PROGRAM
LUNCHEON SATELLITE SYMPOSIUM
S-4
S-4-001
Welcome and Introductions
S-4-002
Is Timing Everything ?
S-4-003
Levitra: The Couple's Treatment Option
Raymond Rosen, USA
S-4-004
Question and Answer, Summary
from Bayer HealthCare
INTERACTIVE SESSION
Amalienborg Palace
C-5
13.30 - 15.00 h
Hall A1
Chair:
13.30 - 15.00 h
Auditorium 15
Penile Surgery - Basics
Chair:
Panel:
C-5-001
Prosthetics – basic approaches
Juza Chen, Israel
C-5-002
Penile anatomy and surgical approaches
Santiago Richter, Israel
C-5-003
Avoiding complications in penile surgery
Benny Ver Heiden, Belgium
Jens Sonksen, Denmark
Ragnar Stien, Norway
HISTORY SESSION
13.30 - 14.30 h
ESSM History Session
Chair:
Dirk Schultheiss, Germany
32
IS-3
‘Wonderful Copenhagen’, K. Bentzen
12.30 - 13.30 h
Hall A1
New Perspectives in ED Management: Regaining Couple
Satisfaction
Chair:
HS-1
Hall A2
HS-1-001
Scandinavian Innovations in Sexual Medicine,
from Bartholin to ESSM 2005
HS-1-002
Surgical Management of Male-to-Female
Transsexualism
Dirk Schultheiss, Germany
HS-1-003
Preputial infubilation: From ancient medicine to
modern genital piercing
J. Mattelaer, Belgium
SCIENTIFIC PROGRAM
PODIUM SESSION
Hall A3
PS-5-046
Sexual dysfunction among women with vulvar
vestibulitis
Christina Damsted Petersen, Denmark
E. Kristensen, A. Giraldi, L. Lundvall
Female in mid-luteal and menstrual phase reveal
specific cerebral activation compared to male
during erotic stimuli using fMRI
Elke Gizewski, Germany
T. Krüger, W. Senf, M. Forsting,
E. Krause
PS-5-047
Effects of an alprostadil cream on sexual arousal response in premenopausal women with
female sexual arousal disorder
Marc Gittelman, United States
Q. P. Liao, M. Zhang, J. Mo, M. Lu
PS-5-048
Effects of hypertension and antihypertensive
treatment with captopril on the isolated rat
vagina
P. Nedergaard, E. Kristensen,
K.-E. Andersson, P. Hedlund
PS-5-049
Distribution of rho-kinase-related proteins and
effects of y27632 in human subepithelial
vaginal arteries
Eginhard Waldkirch, Germany
S. Ueckert, K.-E. Andersson,
W. Kauffels, U. Jonas, P. Hedlund
PS-5-050
Different roles of 5-HT2A and 5-HT2C receptors in regulation of female rat sexual
motivation
Per Nedergaard, Sweden
P. Hedlund, S. Frank Jorgensen
13.30 - 15.00 h
Chairs:
PS-5-041
PS-5
PS-5-042
Changes in female genital sensation - before,
during and after sexual arousal
Yoram Vardi, Israel
I. Gruenwald, I. Gertman, Y. Vardi
PS-5-043
A methodology study to develop and validate
a screening instrument for hypoactive sexual
desire disorder in postmenopausal women
Sandra Leiblum, United States
T. Symonds, J. Moore, P. Soni,
S. Steinberg
PS-5-044
PS-5-045
A conditions of first intercourse and their
influence on later sexual encounters in a
female sample
Stamatis Papaharitou, Greece
P.-S. Kirana, K. Hatzimouratidis,
M. Moraitou, E. Nakopoulou
Ageing and women's sexual health.
Preliminary results of a multivariate analysis
G. Zanni, G. V. Fantini, F. Deho,
A. Briganti, E. Longhi, P. Rigatti,
F. Montorsi, F. Fabbri
POINT-COUNTERPOINT SESSION
14.30 - 15.00 h
Gene-Therapy - An Experimental Tool or a Future
Treatment Option for Erectile Dysfunction
Chair:
Mario Maggi, Italy
ProSpeaker:
ConSpeaker:
CP-2
Hall A2
Trinity J. Bivalacqua, United States
33
SCIENTIFIC PROGRAM
15.30 - 17.00 h
Hall A3
Pharmacology
Chairs:
34
MP-3
MP-3-109
Effects of avanafil, a highly selective phosphodiesterase-5 inhibitor for erectile dysfunction,
on hemodynamics and electroretinogram are
less than sildenafil in anesthetized dogs
Hideki Mochida, Japan
K. Yano, T. Noto, M. Matsukawa,
K. Kikkawa, H. Inoue
MP-3-101
Hemodynamic effects of co-administration of
avanafil and glyceryl trinitrate
Ajay Nehra, United States
MP-3-102
SLx-2101, a new long-acting pde5 inhibitor:
Preliminary safety, tolerability, pk and endothelial function effects in healthy subjects
David Donabedian, United States
P. William, S. Campbell, W. Tong,
P. Sweetnam, M. Willett, B. Roesch,
W. D. Garcia, R. Rosen, I. Goldstein
MP-3-110
Vardenafil 20 mg provides initial and subsequent reliability in penetration and intercourse
completion: The reliability of vardenafil for
erectile dysfunction ii (rely ii) trial
F. Montorsi, E. Rubio-Aurioles,
B. N. Stancil, H. J. Wilkins, L. Valiquette
MP-3-103
Effects on intraocular pressure and ocular
hemodynamics of vardenafil
Murad Basar, Turkey
Y. Karadeniz-Bilgili, B. Unal,
E. Batislam, P. Taner, E. Batislam,
B. Unal, Y. Karadeniz-Bilgili, M. M. Basar
MP-3-111
Female partners of men with erectile dysfunction treated with viagra® (sildenafil citrate)
report greater satisfaction and enjoyment from
sexual intercourse
Andrew R. McCullough, United States
D. L. Creanga, C. R. Pace
MP-3-104
Effects of chronic oral tadalafil administration
on the cavernosal arteries in patients with
Mario Mancini, Italy
F. Nerva, M. Guazzi, G. Contalbi,
G. M. Colpi
MP-3-112
Treatment of Erectile Dysfunction (TED): Focus on
treatment satisfaction of patients and partners
John Chan, Canada
M. Chan, S. Carrier, L. Salgado,
A. Klein, C. Lang, R. Horner,
R. Dickson, G. Brock
MP-3-105
Nonarteritic anterior ischemic optic neuropathy
in men using viagra® (sildenafil citrate) for
erectile dysfunction: A review of >44,800
patients in clinical and observational studies
Ivan P. Levinson, United States
L. Gorkin, R. E. Sobel, R. L. Siegel,
K. Hvidsten
MP-3-113
MP-3-106
Vision disturbances associated with use of
pde5-inhibitors? Analysis of individual case
safety reports in the Swedish and who adverse
drug reaction databases
Lars Ny, Sweden
C. Tukukino, G. Brunlöf
Effect of sildenafil treatment on Self-Esteem
(SE) of patients with Erectile Dysfunction (ED):
A double-blind, placebo-controlled study using
the Self-Esteem and Relationship (SEAR)
Questionnaire
L. Rodriguez Vela, S. Jimenez,
J. Chaves, J. Koskimaki
MP-3-114
Cardiovascular safety update of tadalafil:
Retrospective data analysis from placebo-controlled and open-label clinical trials of tadalafil
comparing as needed dosing, 3 times per week
dosing, and once a day dosing
Graham Jackson, United States
A. Hutter, M. Mittleman, M. Chan,
M. Warner, T. Costigan, G. M. Vail,
R. Kloner
MP-3-115
Sexual rehabilitation after radical retropubic
prostatectomy: A randomised prospective study
on vacuum device and sildenafil vs. alprostadil
and sildenafil
Alessandro Zucchi, Italy
C. Elisabetta, A. Giannantoni, F. Fioretti,
M. Bitelli, M. Porena, L. Mearini
MP-3-107
Rechallenging non-responders to tadalafil and
vardenafil: A real life study
A. Bekos, Z. Tsimtsiou, E. Ioannidis,
D. Hatzichristou, K. Moysidis
MP-3-108
Efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with diabetes
mellitus type 1 and erectile dysfunction in relation to baseline degree of glycaemic control
Dan Ziegler, Germany
F. Merfort, H. van Ahlen, M. Neureither
SCIENTIFIC PROGRAM
ROUND TABLE
15.30 - 17.00 h
The Metabolic Syndrome and Sexual Function
Chair:
R-3
Hall A2
R-3-001
What is the metabolic syndrome?
S. Madsbad, Denmark
R-3-002
The sympathetic nervous system, altered
signalling pathways and sexual dysfunctions
R-3-003
Erectile or sexual dysfunctions, endothelial dysfunction and cardiovascular drugs
Graham Jackson, United Kingdom
R-3-004
Obesity, hyperlipidemia, statins and sexual or
erectile dysfunctions
Katherine Esposito, Italy
SATELLITE SYMPOSIUM
15.30 - 17.00 h
Priapism
Chair:
C-6
Auditorium 15
C-6-001
Biochemistry, etiology and classification of
priapism
C-6-002
Surgical treatment
C-6-003
Non-surgical treatment of prolonged erection
S-5
17.00 - 18.00 h
Hall A1
The Rationale for Testosterone Therapy in Erectile Dysfunction
Chairs:
Peter Lyngdorf, Denmark
S-5-001
The pharmacological and endocrinological basics
of testosterone action for erectile function
Andrea Garolla and Carlo Foresta,
Italy
S-5-002
Review on clinical studies focussed on testosterone and ED including combination therapy with
PDE-V-inhibitors
Tom Trinick, United Kingdom
S-5-003
Clinical experiences with a long-acting testosterone ester (Nebido®) in patients with ED
from Schering AG
35
SCIENTIFIC PROGRAM
ROUND TABLE
08.00 - 09.30 h
CNS Pharmacology and Erectile Dysfunction
Chair:
R-4
Hall A1
08.00 - 09.30 h
Auditorium 15
Treatment of the Nonresponder to Oral Therapy
Chair:
R-4-001
Dopamine receptors and erectile responses
C-7-001
Converting non-responders to responders
R-4-002
Melanocortin receptor agonists to overcome
C-7-002
Surgical Management of the non-responder
to oral therapy
Michael Sohn, Germany
R-4-003
Erectile or sexual dysfunctions in male SSRI
treated patients
Raymond Rosen, United States
C-7-003
Non-oral medical alternatives and vacuum
devices for non-responders to oral therapy
Edoardo S. Pescatori, Italy
PS-6
PODIUM SESSION
08.00 - 09.30 h
Hormones and Sexuality
Chairs:
PS-6-051
Hall A2
Factors associated with sexual attitudes in
paramedical students
E. Nakopoulou, Z. Tsimtsiou,
D. Hatzichristou
PS-6-052
Opinions about sexuality and erectile dysfunction in the general population
R. Opsomer, K. Demyttenaere
PS-6-054
Psychometric parameters of sexual health in
infertile couples due to a male factor.
Preliminary results of a multivariate analysis
A. Gallina, G. Zanni, G. V. Fantini,
F. Deho, A. Briganti, E. Longhi,
P. Rigatti, F. Montorsi, F. Fabbri
PS-6-055
36
C-7
Multicenter study on the prevalence of sexual
symptoms in male hypo- and hyperthyroid
patients
Andrea M. Isidori, Italy
C. Carani, A. Granata, E. Carosa,
M. Maggi, A. Lenzi, E. Jannini
PS-6-056
Increased incidence of male hypogonadism in
type 2 diabetes mellitus
Mario Giuseppe Vetri, Italy
S. Crimi, G. Parrinello, G. Verga,
F. Mangiola
PS-6-057
Association of hypogonadism and type 2
diabetes in men attending an outpatient
erectile dysfunction clinic
M. Maggi, L. Petrone, G. Balercia,
R. Giommi, V. Chiarini, M. Maggi,
F. Lotti, V. Ricca, R. Mansani, G. Forti
PS-6-058
Referrals to a Sexological Clinic - focus on
diagnosis. Are the diagnoses put forward by
the referring health - worker correct?
Äse Klemmensen, Denmark
E. Kristensen
PS-6-059
Long-acting testosterone 1.000 mg - nebido(trade mark) i.m. and modulation of erectile
function in hypogonadal patients
PS-6-060
Are there any differences in breech of sexual
boundaries between patients and clinicians
practising Sexology in the UK?
SCIENTIFIC PROGRAM
Hall A3
MP-4-123
Vibration: Pilotstudy evaluating the effect of
vibration program for women with inactive
pelvic floor
Birthe Bonde, Denmark
Estimation of the indices of the sexual health
of women of the reproductive and menopausal
age
Oksana Romashchenko, Ukraine
O. Romashchenko, S. Melnikov,
I. Gorpinchenko
MP-4-124
Genital vibratory perception threshold
(VPT) measurements in women with sexual
dysfunction and/or sexual pain disorders
Birgitta Hulter, Sweden
MP-4-125
Centrally active agents and female sexual
responses
Salvatore Caruso, Italy
MP-4-126
Phosphodiesterase (pde)5 inhibitors enhance
the endothelium-dependent relaxation of
isolated subepithelial human vaginal arteries
V. Werkström, W. Kauffels, U. Jonas,
P. Hedlund, E. Waldkirch
MP-04-127
Characterisation of neuropeptide Y receptor(s)
in rabbit vagina arterial smooth muscle
Nicholas Edmunds, United Kingdom
K. Aughton, J. Morton, K. Tang,
C. Wayman, M. Jackson
MP-4-128
Psychiatric and sexual status of premenapousal
female patients with Behcet's disease
Murad Basar, Turkey
M. Koçak, G. Vahapoglu, H. Ç. Mert,
S. Gungor, E. Batislam
MP-4-129
Effects of hypertension and captopril treatment
on sexual motivation in female rats
Per Nedergaard, Sweden
P. Hedlund, K.-E. Andersson,
E. Kristensen, A. Giraldi
MP-4-130
A qualitative approach on female masturbation
E. Nakopoulou, S. Papaharitou,
M. Lentziou
08.00 - 09.30 h
Chairs:
Yoram Vardi, Israel
Manuel Mas, Spain
MP-4-116
MP-4-117
MP-4-118
MP-4-119
MP-4-120
MP-4
A psycosexual study of sexual functions during
pregnancy
Elena Longhi, Italy
P. Rigatti, F. Montorsi, A. Salonia
An integrated clinical-psychosexological
approach to female sexual dysfunction
Gabriele Optale, Italy
F. Di Tonno, N. Piazza, C. Pianon,
S. Marin
The relation between sexual dysfunction and
hormone levels in postmenopausal women
Mustafa Delibas, Turkey
T. Akgülen, Ö. Öztürk, G. Günaydin,
A. Tan
Effect of transdermal testosterone (t) on sexual function in premenopausal women with low
libido: A placebo-controlled, randomised, paralel, dose-ranging study
Karen Gardner, Australia
A. Humberstone, S. Davis, R. Norman,
S. O'Neill, M. Redelman,
M. Williamson, B. Stuckey
MP-4-121
Effect of tibolone on sexual function in late
postmenopausal women
Zdravko Kamenov, Bulgaria
M. Todorova, V. Christov, Z. Kamenov
MP-4-122
The underlying socio-cultural factors for lack of
treatment of Female Sexual Dysfunction (FSD)
I. Hattat, E. Akkus
37
SCIENTIFIC PROGRAM
DEBATE
D-2
10.00 - 11.00 h
Rapid Ejaculation
Chair:
Speaker:
Closing Remarks
David Rowland, United States
C-8
11.00 - 12.30 h
Auditorium 15
Sexual Counselling and Therapeutic Approaches
for Non-Experts
Chair:
38
Please join the
Hall A1
C-8-001
How can the therapist help the patient or
couple choose between brief psychodynamic
therapy, relaxation, hypnosis or CBT?
Maire Chevret-Measson, France
C-8-002
Cognitive approaches to sexual and relationship problems
Mehmet Sungur, Turkey
C-8-003
Systemic techniques for sex and relationship
therapy
Jane Ridley, United Kingdom
C-8-004
Establishing telephone and email services for
sexual problems
in Hall A1 at 12.30 h today!
INTERACTIVE SESSION
11.00 - 12.30 h
Peyronies Disease
Chair:
Emre Akkus, Turkey
Panel:
E. Hauck, Germany
Gianfranco Savoca, Italy
Trygve Talseth, Norway
IS-4
Hall A1
SCIENTIFIC PROGRAM
PS-7
PODIUM SESSION
11.00 - 12.30 h
Epidemiology and Risk Factors
Chairs:
Bert-Jan de Boer, Netherlands
Thierry Roumeguere, Belgium
PS-7-061
PS-7-062
PS-7-063
PS-7-064
Hall A2
The prevelance of metabolic syndrome and its
association with erectile dysfunction among
urologic patients: Predictors of increased
erectile dysfunction risk
Omer Demir, Turkey
M. Oder, N. Unlu, C. T. Karatas,
O. Demir, E. Can, B. H. Gumus,
K. Ozer, O. Sahin, A. Esen, K. Bal
Erectile dysfunction predicts extension of coronary artery disease in acute coronary syndromes
Piero Montorsi, Italy
P. Ravagnani, S. Galli, A. Briganti,
A. Salonia, F. Montorsi
Erectile dysfunction and blood pressure among
finnish men
Pekka Kunelius, Finland
H. Vanhanen, O. Lukkarinen,
A. Linnankivi, P. Ohtonen
Prevalence of cardiovascular risk factors in
patients with erectile dysfunction and evaluation of the impact of medical treatment
(blueprospective study).
Bruno Giammusso, Italy
G. Ludovico, M. Soli, L. Rolle,
M. Carrino, F. Romanelli, A. Bertozzi,
G. Savoca, M. T. Particco, F. Colombo
PS-7-065
Associated comorbidities in patients with ed:
A belgian survey in 5625 patients
Thierry Roumeguere, Belgium
H. Van Poppel, C. Schulman, H. Claes
PS-7-066
Association between erectile dysfunction and
sleep disorders measured by self-assessment
questionnaires in adult men
Raphael J. Heruti, Israel
T. Shochat, D. Tekes-Manova,
I. Ashkenazi, D. Justo
PS-7-067
Sexual concerns of the asthmatic patient
Michele Pujos-Gautraud, France
D. Vervloet, C. Rolland, M. Sapene
PS-7-068
Thoughts and views on the sexual well being
of the 50+ population in Belgium
H. Van Poppel
PS-7-069
Sexual desire in men and women in a national
representative Danish population
Lene Falgaard Eplov, Denmark
M. Davidsen, K. Garde, F. KamperJørgensen, A. Giraldi
PS-7-070
Evaluation of the clinimetric properties of lisat-8
questionnaire as a screening tool for erectile
disfunction
J. Rejas, E. Martinez, C. FernandezMicheltorena
39
SCIENTIFIC PROGRAM
11.00 - 12.30 h
Basic Science
Chairs:
MP-5-131
MP-5-132
MP-5-133
MP-5-134
MP-5-135
MP-5-136
MP-5-137
Hall A3
Continuous neurochemical measurement of
cerebrospinal fluid during the human sexual
response cycle
Tillmann Krueger, Switzerland
B. Schiffer, M. Eikermann,
U. Hartmann, M. Schedlowski
Role of calcium in the vasoconstriction of rat
penile arteries
Nuria Villalba, Spain
D. Prieto, U. Simonsen,
E. Stankevicius, A. Garcia-Sacristan
Erectile dysfunction is associated with altered
contractility of penile smooth muscle in men
R. Gonzalez-Corrochano,
A. Fernandez, J. M. La Fuente, F. Rolo,
A. Astobieta, I. Saenz de Tejada,
P. Cuevas
PKC activity contributes to altered contractility
of cavernosal smooth muscle in diabetic men
with erectile dysfunction
A. Fernandez, I. Moncada, A. MartinMorales, A. Allona, I. Saenz de
Tejada, P. Cuevas
The differential effect of ischaemia on nerve
mediated and agonist induced contraction in
corpus cavernosum
C. Y. Li, P. D. Kell, D. J. Ralph,
S. Minhas, C. H. Fry
Cyclic AMP- and cyclic GMP-specific phosphodiesterase (PDE) isoenzymes in human
cavernous arteries - immunohistochemical
distribution and functional significance
S. Ückert, U. Jonas, M. Sohn,
C. G. Stief, K.-E. Andersson,
P. Hedlund
MP-5-138
Repeated PDE5 inhibition increases nitric oxide
synthase gene and protein in diabetic penile
tissue
Byoung Ok Ahn, Republic of Korea
G. J. Ahn, K. K. Kang, M. Yoo,
D. G. Moon, J. J. Kim
MP-5-139
Genomic profiles of experimental diabetes and
its modulation by chronic phosphodiesterase 5
inhibition
Gook Jun Ahn, Republic of Korea
H. K. Chung, K. K. Kang, B. O. Ahn,
M. Yoo
MP-5-140
Avanafil has the potential for the treatment of
erectile dysfunction with selective phosphodiesterase-5 inhibition
Kenji Omori, Japan
H. Mochida, K. Fujishige, T. Noto,
H. Inoue, K. Yano, T. Sasaki,
T. Kobayashi, K. Kikkawa, J. Kotera
MP-5-141
Sildenafil increases erection hardness by potentiating pudendal artery blood flow and intracavernosal pressure in the anaesthetised dog
A. Burden, J. Casey, S. Hornby
MP-5-142
Superoxide derived from NADPH oxidase
mediates the upregulation of PDE5 expression
by nicotine in rabbit vascular smooth muscle
cells
Matthew Hotston, United Kingdom
MP-5-143
Sildenafil impairs implicit learning in rats
A. Agar, C. Ozdemir
MP-5-144
Non-genomic, in vitro effects of testosterone
and dihydrotestosterone on human cavernous
arteries and corpus cavernosum
S. Ückert, D. Schultheiss, U. Jonas,
M. Sohn, K.-E. Andersson, P. Hedlund
MP-5-145
The role of rho/rhokinase pathway in serotonin-induced contraction in human corpus
cavernosum
Omer Demir, Turkey
B. C. Soner, O. Demir, S. Gidener,
A. Esen, M. Nergis
Mapping the endothelium and vegf expression
in corpus cavernosum of diabetic rats
Janete Santos, Portugal
C. Costa, D. Neves, P. Vendeira,
N. Tomada
12.30 - 13.00 h
40
MP-5
Closing Remarks
Hall A1
POSTER
POSTER PRESENTATIONS
Monday, 5 December - Wednesday, 7 December 2005
The poster exhibition will be located next to the
Exhibition Hall of the Bella Center. The poster exhibition is open to all conference delegates on:
from 09.00 h to 17.30 h
from 09.00 h to 17.30 h
from 09.00 h to 13.00 h
The unmoderated posters will be arranged according
to topics and will be numbered within these topics.
P-01-147
P-01-148
from 15.00 h to 15.30 h
from 15.00 h to 15.30 h
P-01-151
Effects of sildenafil on men with eugonadotropic hypogonadism
Dimitrios Baltogiannis, Greece
S. Tsambalas, E. Grammeniatis,
I. Miyagawa, N. Sofikitis, A. Sylakos
Neurotransmitters regulating the smooth
muscle of seminal vesicle
Weifu Wang, People’s Republic of China
C. Fry, P. Kell, S. Minhas, D. J. Ralph,
C. Wu
P-01-152
The effect of temperature on cavernosal
smooth muscle contractile function
C. Y. Li, P. D. Kell, D. J. Ralph,
S. Minhas, C. H. Fry
Neurotransmitters regulating the smooth
muscle of vas deferens
Weifu Wang, People’s Republic of China
C. Fry, P. Kell, S. Minhas, D. J. Ralph,
C. Wu
P-01-153
Functional muscarinic receptor subtypes in
guinea-pig corporal smooth muscle
Chi-Ying Li, United Kingdom
P. Kumar, C. Fry, P. Kell, D. Ralph,
S. Minhas
Sildenafil increases erection hardness by
improved penile oxygenation in the
anaesthetised dog
A. Burden, J. Casey, S. Hornby
P-01-154
The therapeutic effect of alt-711 on erectile
function in rats treated with high level ages
(advanced glycation end products) containing
diet
R. Gurkan, G. Sagdic, A. Sanli,
A. Baykal, N. Gurbuz
P-01-155
Effect of chronic tadalafil administration on
penile hypoxia induced by cavernous
neurotomy in the rat
L. Vignozzi, S. Filippi, S. Donati,
M. Luconi, X.-H. Zhang, S. Ambrosini,
G. B. Vannelli, G. Forti, M. Maggi,
M. Maggi, G. Forti, V. Mirone
BASIC SCIENCE
P-01-146
The moderated posters will be located in the session
Hall A3 where the moderated poster session will
take place. All posters will be set-up for the whole
period of the Congress.
Interested participants can meet the authors for discussions of their poster presentation during the following time:
P-01-149
Structural Brain Abnormalities in the
Frontostriatal system and cerebellum in
pedophilia
Boris Schiffer, Germany
E. Gizewski, M. Schedlowski, N. Leygraf,
M. Forsting, T. Krüger, T. Paul
P-01-150
Bilateral electrostimulation of the neurovascular bundles and pressure response of the male
membraneous urethra during nerve sparing
prostatectomy
Christof van der Horst, Germany
C. M. Naumann, G. Böhler, C. Amiel,
F. J. Martinez Portillo, P. M. Braun,
K. P. Juenemann, C. Seif
41
POSTER
P-01-156
Testosterone restores diabetes-induced erectile
dysfunction and sildenafil responsiveness in
two distinct animal models of chemical diabetes
S. Filippi, L. Vignozzi, X.-h. Zhang,
M. Luconi, S. Donati, G. Forti, M. Maggi
P-02-164
Functional responses of isolated human seminal
vesicle tissue to selective phosphodiesterase
inhibitors
F. Scheller, S. Machtens, U. Jonas,
S. Basrafshan
P-01-157
The effect of acute and subacute stress on
endothelial and erectile functions in rats
Omer Demir, Turkey
N. Murat, O. Demir, E. Can,
S. Gidener, A. Esen, E. Bal
P-02-165
The use of the female sexual function index to
assess the efficacies of an alprostadil cream in
a placebo-controlled, double-blind study in
patients with female sexual arousal disorder
Q. P. Liao, M. Zhang, J. Mo, M. Lu
P-02-166
Effect of Korean Red Ginseng on sexual arousal
in hyperlipidemic female rats
Kwangsung Park, Republic of Korea
K. J. Oh, H. S. Lee, K. Ahn, Y. I. Park
P-02-167
A placebo-controlled, double-blind study of the
efficacy and safety of an alprostadil topical
cream in patients with female sexual arousal
disorder
Q. P. Liao, X. H. Song, L. Geng,
X. P. Wang, J. Mo, M. Lu
P-02-168
Synergistic effect of meatal application of
dyclonine/alprostadil cream for the treatment
of Early Ejaculation (EE) in a double-blind and
crossover study
J. Mo, M. Lu, M. Gittelman
P-02-169
Anejaculation and Orgasmic disorders in men
after penile implant surgery
Santiago Richter, Israel
I. Leibovitch, R. Alkalay
P-02-170
An open pilot study of the Sexual Assessment
Monitor (SAM)
Mike Wyllie, United Kingdom
W. Dinsmore
EJACULATORY AND AROUSAL DISORDERS
P-02-158
Alfuzosin pharmacotherapy for primary premature ejaculation
Vipan Bhatia, United Arab Emirates
P-02-159
Dapoxetine inhibits p-chloroamphetamineinduced ejaculation in anesthetized rats
J. Bernabe, P. Gengo, D. Roussel,
P. Clement
P-02-160
Ejaculatory disorders following administration
of a-adrenergic receptor antagonists for the
treatment of benign prostatic hyperplasia (bph)
Marco Grasso, Italy
S. Blanco, F. Fortuna, C. Lania
P-02-161
Capturing outcomes of Premature Ejaculation
(PE) with single items
Carol Jamieson, United States
M. Rothman, P. McNulty, K. F. Ho,
D. Patrick
P-02-162
P-02-163
42
Dapoxetine, a new on-demand treatment for
premature ejaculation, exhibits rapid singleand multiple-dose pharmacokinetics
Nishit Modi, United States
M. Simon, D. Lin, D. Desai, S. Gupta,
M. Dresser
Dapoxetine treatment of men with premature
ejaculation: Dose-finding analysis
Anders Nilsson-Neijber, United States
S. Althof, M. Gittelman, C. Steidle,
K.-F. Ho, S. Kell, W. Hellstrom
EPIDEMIOLOGY, HORMONES AND RISK FACTORS
P-03-171
The effect of noisy working environment on
sexual function
Murad Basar, Turkey
O. Cirpar, O. K. Arikan, E. Batislam,
D. Tuglu
POSTER
P-03-172
Attitudes of patients and physicians to erectile
dysfunction in the Belgian 50+ population
Hubert I. M. Claes, Belgium
H. Van Poppel
P-03-173
High prevalence of erectile dysfunction in
young male patients after intramedullary
femoral nailing
Richard Mallet, France
X. Game, N. Berrogain, M. Mouzin,
B. Malavaud, R. Pascal
P-03-174
P-03-175
Pattern of erectile dysfunction in Qatar
Krishna Prasad Venkiteswaran, Qatar
A. Al-Ansari, A. Shamsudini,
E. F. El Malik
Effects of androgen replacement therapy on
cardiac risk markers
Sinan Aksit, Turkey
M. Aydin, F. B. Aksungar, A. Eren,
L. Saporta, A. Eroglu
P-03-183
Diagnostic measures in verifying of acute
Cowperitis
Vladimir Startsev, Russia
S. Gorelov, K. Movchan, B. Komiakov,
L. Strokova
P-03-184
The correlation between the severity of erectile
dysfunction and demographic characteristics in
a broad cohort of Belgian men with erectile
dysfunction
T. Roumeguere, H. Van Poppel,
C. Schulman
P-03-185
The ED helpline summary data on male callers
highlighting regional differences
I. Hattat, E. Akkus
P-03-186
Hypnotics and npt test: A promising association
A. L. Romano, A. Guarneri, V. Inneo,
F. Colombo, E. Austoni
P-03-187
A double-blind, randomized, placebo-controlled
cross-over study on the effects of testosterone
(testogel) plus sildenafil on bone and metabolic
parameters in men with mild hypogonadism
and erectile dysfunction
E. A. Greco, D. Canale, E. Macchia,
V. Bonifacio, A. M. Isidori, V. Fierro,
E. Giannetta, C. Pozza, E. A. Jannini,
G. Spera, A. Lenzi, A. Fabbri, A. Lenzi
P-03-176
Sexual dysfunction in female patients
Andrzej Lecki, Poland
P-03-177
Increased incidence of male hypogonadism in
type 2 diabetes mellitus
Filomeno Mangiola, Italy
S. Crimi, G. Verga, G. Parrinello,
M. G. Vetri
P-03-178
Diabetes prevelence in wales
Tom Robinson, United Kingdom
P-03-179
Effects of serum sex steroids on autonomic
function
Murad Basar, Turkey
M. Dogru, H. C. Mert, E. Yilmaz,
E. Batislam
P-03-188
The effects of testosterone replacement
therapy on late onset hypogonadism:
Testosterone undecanoate versus
transdermal testosterone gel
Je Jong Kim, Republic of Korea
D. G. Moon, H. S. Park, J. H. Bae
Sexuality in patients with Spinal Cord Injuries
(SCI) due to attempted suicide
Giuseppe Lombardi, Italy
G. Panariello, G. Giubilei, G. del
Popolo, N. Mondaini
P-03-189
The potential role of family doctors and cardiologists in assesment of men sexual function
Rafael Badalyan, Armenia
A. Hambaryan, I. Aghajanyan
P-03-190
Ethnic origin and erectile dysfunction:
Survey of a multiracial population
Filippo Sogni, Italy
C. Anderson, L. E. K. Grover,
C. Beighton, G. Pretti, E. Kocjancic,
B. Frea, P. Gontero
P-03-180
P-03-181
The effects of testosterone replacement on the
prostate in the aging male
Michael Kirby, United Kingdom
P-03-182
Genital herpes, sexuality and life satisfaction
Kerstin Fugl-Meyer, Sweden
K. Fugl-Meyer
43
POSTER
P-03-191
P-03-192
Safety issues in the androgen replacement
therapy of the ageing male: Results of a
meta-analysis
E. Giannetta, C. Pozza, A. Aversa,
V. Bonifacio, A. Fabbri, A. Lenzi
P-03-193
The ageing woman
Alessandra Graziottin, Italy
P-03-194
The effect of different questionnaires on the
prevalence of ED, The ENIGMA-study
Bert-Jan de Boer, Netherlands
P-03-195
Can Doppler ultrasonography show endothelial
dysfunction in erectile dysfunction patients
with metabolic syndrome?
Omer Demir, Turkey
T. Demir, M.-S. Aykut-Kefi,
S.-Y. Abdurrahman-Comlekci,
A. Esen, S. Yasil
P-03-196
P-03-197
P-03-198
P-03-199
44
Influence of benign prostatic hyperplasia and
male accessory gland infections on erectile
function and ejaculation: review of 18000
questionnaires
A. Aversa, D. Gianfrilli, E. Greco,
V. Fierro, G. Zizzo, E. Jannini,
A. Fabbri, A. Lenzi
The effect of consultant gender on international
index of erectile function form:
Multi-centric analysis
Omer Demir, Turkey
M. O. Sahin, E. Bal, E. Can,
O. Cakmak, A. Bolukbasi, A. Esen,
M. Oder
Can we help our men with LUTS to save their
sexual health after special treatment?
Vladimir Startsev, Russia
I. Pouline, S. Lefterov, S. Gorelov
A prospective study to document the incidence
and associations of sexual dysfunction in survivors of intensive care treatment
John Griffiths, United Kingdom
J. Quinlan
Psycho-biological correlates of smoking in
patients with erectile dysfunction
E. Mannucci, L. Petrone, G. Forti,
M. Maggi, G. Forti, A. Cilotti, M. Maggi,
R. Mansani, F. Lotti, R. Giommi, V. Ricca,
V. Chiarini, G. Balercia
P-03-200
Sexual life and dysfunctions in patients with
pelvic floor dyssynergia: An observation on
eight women
Giorgio Corretti, Italy
C. Nisita, F. Mungai, S. Cortopassi,
F. Lemmi, C. Stasi, M. Bellini
P-03-201
Low scores in the sexual health inventory for
men questionnaire may indicate sexual
disorders other than erectile dysfunction
Raphael J. Heruti, Israel
T. Shochat, I. Ashkenazi, D. Justo,
R. J. Heruti
P-03-202
Influence of change of a testosterone level on
development of the metabolic syndrome and
Alexander Pechersky, Russia
V. Semiglazov, O. Loran, V. Mazurov,
A. Karpischenko, A. Nikiforov,
N. Kalinina, L. Drygina, N. Davydova,
M. Skorobogatikh, A. Pechersky
P-03-203
Does have long-acting testosterone injection nebido- (trade mark) an impact on dehydrotestosterone (dht)?
GENERAL ISSUES IN SEXUAL MEDICINE
P-04-205
Did Phosphodiesterase type-5 inhibitors revolutionise awareness and treatment of erectile
dysfunction
Shawket Alkhayal, United Kingdom
V. Lehmann, P. Thomas, S. Khan
P-04-206
How incontinence affects the sexual life after
the Laparoscopic Radical Prostatectomy
Ioan Coman, Romania
F. Nechita, N. Crisan, B. Feciche,
D. Porav Hodade, B. Petrut
P-04-207
Tribulus terrestris L. effects on the sense of
wellbeing and the sexual response of Diabetic
men
Kiagus M. Arsyad, Indonesia
POSTER
P-04-208
Effect of short term statin treatment on autonomic and erectile function
Murad Basar, Turkey
M. T. Dogru, A. Simsek, E. Yuvanc,
M. Guneri, H. Ebinc, E. Batislam,
A. Simsek, M. M. Basar, E. Yuvanc,
E. Batislam, H. Ebinc, M. Guneri
P-04-209
Testosterone enhance the effect of sildenafil in
metabolic syndrome induced erectile
dysfunction
Vasile Coca, Romania
G. Nicolescu, N. Hancu
P-04-210
Erectile dysfunction therapy: An adirs survey
Antoine Lemaire, France
M. H. Colson, A. Corman,
B. Alexandre
P-04-211
Data from calls received at the help-line of the
“Asociacion Espanola para la Salud Sexual”
(AESS), a not-for-profit association, during a
national awareness campaign on sexual health
in Spain from February to August 2005
Milly Lemos, Spain
A. Martin Morales, I. Moncada
Iribarren
P-04-212
Trauma indicated vaginismus: A case report
Helmut W. Ott, Austria
P-04-213
The evaluation of loco-regional lymph nodes in
patients with penile cancer using CT and MR
imaging
Oliver Kayes, United Kingdom
C. Li, C. Allen, E. Simpson, D. Ralph,
S. Minhas
P-04-214
Evidence of a pre-natal androgenization deficit
in Male-to-Female transsexuals. Assessment of
its biological mechanism
Manuel Mas, Spain
P. Hernandez, P. Gutierrez, E. Salido,
C. Alonso
P-04-215
Is there a correlation between erectile function
outcome and histological findings in patients
undergoing bilateral nerve sparing radical
retropubic prostatectomy?
M. Freschi, G. Zanni, A. Gallina,
A. Briganti, F. Fabbri, P. Rigatti,
F. Montorsi, F. Deho
P-04-216
Quality of life in patients submitted to external
beam radiotherapy as adjuvant treatment after
radical prostatectomy. Preliminary results
L. Da Pozzo, F. Fazio, V. Scattoni,
P. Rigatti, F. Montorsi, C. Cozzarini
P-04-217
A pilot study: The impact of training primary
care physicians, on their readiness to treat
patients with erectile dysfunction, evaluated by
changes in pde5 inhibitors prescription rate
Arik Shechter, Israel
I. Gruenwald, Z. Shechner,
D. Wattelman, I. Lapidot, I. Gertman,
R. Aharon, Y. Vardi
P-04-219
Outcome of a ssr (sexual surgical reconversion)
operation performed on 36 m-to-f transsexuals
Paolo Verze, Italy
A. Palmieri, N. Longo, F. Fusco,
A. Cola, V. Mirone, C. Imbimbo
P-04-220
The importance of addressing partner’s response to male sexual dysfunction - An overview of
608 patients presenting at a sexual dysfunction
clinic
Victoria Lehmann, United Kingdom
S. Khan, P. Thomas, S. Alkhayal
P-04-221
Distinct profiles of men self-reporting erectile
dysfunction and premature ejaculation:
Data from a help-line
L. Athanasiadis, E. Nakopoulou,
P.-S. Kirana, M. Iraklidou, G. Salpiggidis,
K. Hatzimouratidis, D. Hatzichristou
P-04-222
WWW.SUBSEX.DK, sextherapy and psychotherapy in cyberspace
Gert Erichsen, Denmark
P-04-223
Nipple stimulation and sexual arousal in young
men and women
C. Meston, R. Levin
P-04-224
Postoperative sexual function in patients
undergoing nerve-sparing radical retropubic
prostatectomy: The role of the “largest volume
surgeon”
A. Galina, G. Zanni, A. Sacca,
E. Farina, F. Deho, L. Barbieri,
A. Briganti, P. Rigatti, A. Salonia
45
POSTER
P-04-225
The effects of the pollen extract preparation
prostat/poltit® on lower urinary tract symptoms in patients with chronic non-bacterial prostatitis/chronic pelvic pain syndrome: A randomized, double-blind, placebo-controlled study
James Elist, United States
P-05-233
Erectile dysfunction in males treated with antihypertensive drugs - a review of spontaneous
reports in the Swedish & who adverse drug
reaction databases
Viktoria Werkström, Sweden
P. Hedlund, E. Ekman
P-04-226
Psycho-biological correlates of free-floating
anxiety symptoms in male patients with sexual
dysfunctions
L. Petrone, E. Mannuci, G. Forti,
M. Maggi, G. Forti, M. Maggi, F. Lotti,
R. Giommi, G. Balercia, V. Ricca
P-05-234
Oral polypharmacotherapy with Vardenafil and
Alfuzosin for erectile dysfunction
Vipan Bhatia, United Arab Emirates
P-05-235
Effect of treatment with Sildenafil on
self-esteem (SE) in erectile dysfunction (ED)
patients with normal baseline SE
Jose Chaves, Spain
I. Moncada, E. Hernandez,
S. Jimenez, C. Wohlhuter, J. Chaves
P-05-236
Open label, multicenter, crossover study of sildenafil citrate and tadalafil in men with erectile
dysfunction naive to phosphodiesterase 5 inhibitor therapy: Psychological and interpersonal
outcomes
V. Gentile, F. Pirozzi Farina, Y. Zhao,
L. M. Harrison, A. Beardsworth,
G. Hackett
P-05-237
Efficacy of tadalafil in Egyptian and Turkish
men with erectile dysfunction
Ahmet Adil Esen, Turkey
A. Kadioglu, I. Khalaf, K. Z. Shoair,
A. Beheiry, W. C. Wang, V. Kopernicky,
M. Saylan
P-05-238
Vardenafil improves erection quality assessed
by the novel erection quality scale in the broad
population of men with erectile dysfunction
G. Brock, G. Karlin, P. Pommerville,
X. Y. Huang, K. Bangerter, Z. HermanGnjidic, L. Derogatis, R. C. Rosen
P-05-239
Vardenafil improves treatment satisfaction and
sexual pleasure in men with erectile dysfunction
and their partners
G. Brock, G. Karlin, P. Pommerville,
X. Y. Huang, K. Bangerter, Z. HermanGnjidic, L. Derogatis, R. C. Rosen
P-04-228
P-04-229
P-04-230
How Laparoscopic Radical Prostatectomy influence the men’s sexual life: Erections and the
fear of the cancer
Ioan Coman, Romania
F. Nechita, N. Crisan, D. Porav
Hodade, B. Feciche, B. Petrut
The evaluation of implementing the
Laparoscopic Radical Prostatectomy from the
sexual life point of view
Ioan Coman, Romania
P. H. Daniel, D. V. Stanca, R. Cota,
N. Crisan, B. O. Feciche, F. Nechita,
B. JalaLizadeh, B. Constantin, C. Tudor,
B. Petrut
Prospective study on the effects of a penile
stretching system (Phallosan) for penile
augmentation in patients with normal sized
penisses
Michael Sohn, Germany
PHARMACOLOGY / PHARMACOTHERAPY
P-05-231
P-05-232
46
Sexual adverse reactions of drugs used for
psychiatric disorders - analysis of individual
case safety reports in the swedish and who
adverse drug reaction databases
Lars Ny, Sweden
P. Hedlund, C. Tukukino
Methylene blue in the treatment of intraoperative penile erections during endoscopic surgery
C. M. Naumann, C. Seif, N. Fillipow,
P. M. Braun, K. P. Jünemann,
F. J. Martinez Portillo
POSTER
P-05-240
Viagra® (sildenafil citrate) 100mg helps men
with erectile dysfunction achieve completely
hard erections and improved sexual intercourse
success, enjoyment, and satisfaction
D. L. Creanga, I. P. Levinson
P-05-241
Improved erection hardness is associated with
sexual enjoyment, satisfaction, and confidence
in men with erectile dysfunction (ED) treated
with ViagraG (sildenafil citrate)
D. Creanga, V. Stecher
P-05-242
Viagra (Sildenafil Citrate) normalizes the psychosocial impact of erectile dysfunction
L.-J. Tseng, V. Stecher
P-05-243
P-05-244
P-05-248
The Real-Life Safety and Efficacy of Vardenafil
(REALISE) - Subgroup analysis of patients with
serious conditions (radical prostatectomy or
spinal cord injury)
Kathrin Stauch, Germany
H. Landen, H. van Ahlen
P-05-249
A phase III study to evaluate the efficacy and
safety of udenafil in korean ed patients
Je Jong Kim, Republic of Korea
H. K. Choi, S. C. Kim, S. W. Kim,
S. W. Lee, J. K. Suh, D. Y. Yang,
J. S. Paick, T. Y. Ahn
P-05-250
Factors predicting a poor response to sildenafil
citrate in men with erectile dysfunction
Manuel Mas, Spain
P. Hernandez, P. Gutierrez
P-05-251
The effect of sildenafil treatment on dehydroepiandrosterone sulfate levels in patients with
Altug Tuncel, Turkey
M. Ferhat, M. M. Basar, A. Atan,
U. Tekdogan
P-05-252
Characteristics associated with Sildenafil
Citrate treatment satisfaction
Ofra Kalter-Leibovici, Israel
Y. Kuchnir, A. Ronen, E. TenenbaumKoren, Y. Kerbis, J. Chen
P-05-253
Patient satisfaction and psychological and interpersonal outcomes with erectile dysfunction
treatments in treatment-naive patients:
Results from the Erectile Dysfunction
Observational Study (EDOS)
Alexander von Keitz, Germany
A. Riley, H. Buettner, J. Bertsch,
A. Beardsworth, S. Kontodimas
P-05-254
Correlation of functional outcome and treatment satisfaction in patients with erectile
dysfunction and their partners, when treated
with vardenafil
O. Collins, D. Ralph, I. Eardley, P. Kell
P-05-255
Effect of sildenafil citrate on serum malondialdehyde, erythrocyte superoxide dismutase,
erythrocyte glutathione peroxidase and
catalase levels in healthy men
Mustafa Burak Hopcan, Turkey
S. Soyupek, A. Kosar, T. A. Serel,
R. Sütcü, H. Perk
®
The effect of vardenafil (Levitra) on endothelial
function of cavernous arteries in patients with
Evsey Mazo, Russia
A. Stanislav, O. Ruslan, V. Iremashvili,
S. Gamidov
Vardenafil 20 mg improves satisfaction with
sexual function and treatment in men with
Luc Valiquette, Canada
V. Patel, S. Mahajan, B. N. Stancil,
K. Edmunds, Vardenafil Study Group
P-05-245
Pharacokinetics of avanafil, a new PDE5 inhibitor being developed for treating erectile dysfunction
Craig Peterson, United States
D. Swearingen
P-05-246
Oxygenation of the corpora cavernosa in the
treatment of mild and moderate erectile
dysfunction cases with Tadalafil
Mariano Rossello, Spain
A. Mus, G. Conde
P-05-247
The Real-Life Safety and Efficacy of Vardenafil
(REALISE) - Subgroup analysis of patients with
cardiovascular diseases (diabetes mellitus or
hypertension)
Kathrin Stauch, Germany
H. Landen, H. van Ahlen
47
POSTER
P-05-256
The Impact of Sildenafil (Viagra) on the selfesteem in patients with erectile disfunction and
concomitant Pathologies: VESAR Study
Venancio Chantada, Spain
F. Cabello, F. Forá, A. Calle, J. Rejas
P-05-257
Early titration to 100mg and customized dosing
instructions improves patient response to
treatment with ViagraG (sildenafil citrate) for
Andrew R. McCullough, USA
A. R. Crowley, H. de Riesthal,
R. L. Siegel, L.-J. Tseng
P-05-258
Women’s satisfaction with sexual intercourse is
associated with their partner’s improved erectile function and satisfaction after treatment of
erectile dysfunction with Viagra® (sildenafil
citrate)
Andrew R. McCullough, United States
L.-J. Tseng, R. L. Siegel
P-05-260
Efficacy of sildenafil 150 mg on demand in non
responders to the maximum recommended
dosing of phosphodiesterase-5 inhibitors.
Angelis Konstantinopoulos, Greece
P-05-261
How do the three pde-5 inhibitors work in the
same population: Open label cross-over
observational and comparative study
P-05-262
Cardiovascular safety of tadalafil in a cohort of
users in England
Lorna Hazell, United Kingdom
L. Wilton, S. Shakir, A. Boshier,
S. Harris
P-05-263
Preference for tadalafil vs sildenafil citrate in
the treatment of erectile dysfunction in
Canadian observational study
Lee Jay, Canada
P. Pommerville, G. Brock, R. Gagnon,
P. Mehta, M. Krisdaphongs, J. Chan,
R. Dickson, M. Chan
P-06-265
Neo-urethral reconstruction in Pryor phalloplasty for sex-reassignment surgery: Notes of
technique
G. Liguori, S. Bucci, E. Belgrano,
C. Trombetta
P-06-266
Evaluation of post-operative residual function
of corpora cavernosa after soft penile
prosthesis implant for peyronie’s disease
Marco Grasso, Italy
F. Flavio, B. Salvatore, L. Caterina
P-06-267
Traumatic rupture of penis: our experience on
39 patients
Virgil Iconaru, Romania
V. Ambert, V. Jinga, A. H. Ateia,
M. Muresan, S. Persu
P-06-268
The role of magnetic resonance imaging in
staging primary penile cancer
Oliver Kayes, United Kingdom
C. Hare, P. Kumar, D. Ralph,
S. Minhas
P-06-269
Congenital ventral penile deviation (CVPD):
A modified technique of corporoplasty
Andrew Sytenko, Ukraine
K. Nurimanov, I. Gorpynchenko
P-06-270
Penile and scrotal lymphedema:
Surgical management
N. Zozas, G. Perlepes, A. Tsidavis,
D. Petsis
P-06-271
Radical penectomy for advanced penile
carcinoma
G. Perlepes, N. Zozas, A. Tsidavis,
D. Petsis
P-06-272
A series feminizing operation on intersex in
one stage
Hui Zhu, People’s Republic of China
Y. Long, Y. Cui, D. Long, S. Perovic,
H. Shen, Z. Cai
P-06-273
The characteristics of peyronie’s disease in the
symptomatic and non-symptomatic patients
Murat Cakan, Turkey
M. Topcuoglu, M. Aldemir,
F. Yalcinkaya, M. U. Altug, F. Demirel
SURGERY AND PEYRONIES DISEASE
P-06-264
48
The scalp wound penis and scrotum
Evgeni Bakurov, Russia
J.A. Abayan, V.P. Miroshnikov,
V.V. Mitusov
POSTER
P-06-274
Shock wave therapy in peyronie’s disease:
Its role needs redefined
Sudhanshu Chitale, United Kingdom
P-06-275
Surgical treatment of peyronie’s disease. Use
of free auto graft of buccal mucosa and free
auto graft of saphenous vein
C. Konstantinidis, N. Kalogeropoulos,
W. Perdzynski, M. Djordjevic,
S. Perovic
P-06-276
P-06-277
P-06-278
P-06-279
P-06-280
P-06-281
The natural history of peyronie’s disease
Marco Grasso, Italy
B. Salvatore, F. Flavio, L. Giuseppe,
B. Liliendal
Decortication of plaque with plicature of
albuginea in the treatment of Peyronie’s
Disease. Preliminary results
Giandomenico Passavanti, Italy
P. Valerio, B. Alessandro
Penile cancer. Repair of external meatus
stenosis and penile elongation
S. Andreadakis, A. Papatsoris,
N. Kalogeropoulos, M. Djordjevic,
S. Perovic
The urological prosthetic surgeon? Should the
implantation of both penile prostheses and artificial urinary sphincters only be performed by a
small number of surgeons based in designated
centres?
Duncan Summerton, United Kingdom
Alterations of the localization of the deformity
in Peyronie patients under medical treatment
Tolga Akman, Turkey
O. Sanli, L. Gurkan, F. Akbulut,
M. Cosar, M. Atar, K. Ates
Concurrent dual inflatable penile prosthesis and
incontinence implant after radical surgery.
Transversal incision approach. Our preliminary
experience
Omidreza Sedigh, Italy
M. Paradiso, R. Rossi, F. Liberale,
U. Ferrando
P-06-282
Penile implant plus albuginea modelling in
patient with kidney and pancreas
transplantation
M. Paradiso, F. Lasaponara, R. Rossi,
M. E. Graziano, F. Liberale,
U. Ferrando
P-06-283
Penile rehabilitation and recovery penile length
following radical prostatectomy: 5 years
follow-up
M. Paradiso, A. Abbona, G. L. Milan,
M. E. Graziano, U. Ferrando
P-06-284
Clinical anatomical study: Does release of
ligaments provide real penile lengthening?
Zhiming Cai, People’s Republic of
China
Y. Long, Y. Cui, D. Long, H. Zhou,
G. Li, H. Zhang, S. Perovic, H. Zhu
P-06-285
The pathogenesis of peyronie’s disease:
A state of altered wound healing
K. B. Lim, A. Bella, B. S. Gan,
L. DeYoung
P-06-286
Second-hand surgical procedure for failing of
penile prosthesis. Analysis of surgical, functional
results and risk factors about our experience
on a series of 37 patients
Jack-Charles Tremeaux, France
P-06-288
Original technical modification of the nesbit
corporoplasty
Luigi Rolle, Italy
A. Tamagnone, M. Timpano,
D. Fontana, C. Ceruti
P-06-289
Correction of erectile dysfunction and penile
curvature secondary to peyronie disease with
penile prosthesis implantation and tunica
albuginea plication
Luigi Cormio, Italy
M. De Siati, R. Piccinni, A. Traficante,
G. Carrieri, P. Annese
P-06-290
Vascular injuries mimicking penile fracture
Juza Chen, Israel
Y. Bar-Yosef, A. Beri, G. Lidawi,
A. Greenstein, H. Matzkin
49
POSTER
P-06-291
ShaeerShaeers penile lengthening procedure
Osama Shaeer, Egypt
K. Shaeer
P-06-292
Subjective outcome measures of Extracorporeal
Shock Wave Therapy for Peyronie Subjective
outcome measures of Extracorporeal Shock
Wave Therapy for Peyronies disease
Shawket Alkhayal, United Kingdom
P-07-301
Simultaneous screening for erectile dysfunction
and prostatic cancer in a male population over
50 years old
Ioan Coman, Romania
N. Crisan, B. Feciche, Z. A. Mihaly,
D. Porav-Hodade
P-07-302
Satisfaction with erectile dysfunction therapy
as assessed by the erectile dysfunction inventory of treatment satisfaction correlates
positively with perceived hardness of erections
achieved with Viagra® (sildenafil citrate)
D. L. Creanga, I. P. Levinson
P-06-293
Treatment of penile curvature and penile
shortening with patented silicone block
James Elist, United States
P-06-294
Phalloplasty-a penile surgery for sexual
satisfaction
Alexander Krakovsky, United States
P-07-303
A new corporoplasty without circumcision in
congenital penile recurvatum
G. Alei
Health information about erectile dysfunction
on the internet: Quality in English and Arabic
Soliman Ewis, Qatar
N. Afifi, H. Noureldin
P-07-304
Erectile dysfunction, constructs of masculinity,
and quality of life in the Multinational MALES
Study
R. C. Rosen, M. Sand, A. Nadel,
I. Eardley
P-07-305
Prevalence of comorbidity among men with ED
in the MALES 2004 Longitudinal Cohort
C. Niederberger, R. C. Rosen,
M. Sand, I. Eardley
P-07-306
Hypnotics and npt test: A promising association
A. L. Romano, V. Inneo, A. Guarneri,
F. Colombo
P-07-307
Erectile dysfunction as health state marker:
A predictor of ischemic cardiopathy in primary
attention
Lorenzo Guirao, Spain
L. Garciá-Giralda, I. Casas,
J. V. Alfaro, J. A. Ruiz Ros
P-07-308
The importance of patient organizations in
approaching ED Patient & Partner
I. Hattat, E. Akkus
P-07-309
Do IIEF scores correlate with men’s perception
of their erectile function? A comparison with
the SCSF
K. Moisidis, Z. Tsimtsiou,
D. Hatzichristou, M. Kantziou
P-06-295
P-06-296
P-06-297
Original space maintainer device in penile
lengthening: A new technique
G. Alei
“Pressure against incision” of tunica albuginea
as a new method of bleeding control in
operations of penile curvature
Wojciech Perdzynski, Poland
ERECTILE DYSFUNCTION
P-07-298
Venogenic erectile dysfunction in
klippel-trenaunay syndrome
Vineet Agrawal, United Kingdom
C. Li, S. Minhas, D. Ralph, O. Kayes
P-07-299
Comparison of international index of erectile
function (iief) with nocturnal penile tumescence
and rigidity (nptr) testing in evaluation of
Murat Akand, Turkey
O. Yaman, O. Gulpinar, K. Anafarta,
Z. Tokatli
P-07-300
50
Young men with erectile dysfunction: To young
to be true?
Roberto Casella, Switzerland
T. Sulser, K. Lehmann, L. Ronci
POSTER
P-07-310
Rifampin gentamycin combination is an ideal
irrigating solution in penile implant surgery
Tony John, United States
A. Rajpurkar, M. Fairfax, C. Dhabuwala
P-07-311
Factors that predict switching phosphodiesterase type 5 inhibitor medication in the United
Kingdom
Philip Kell, United Kingdom
S. Morant, J. Harnett, S. Bridge,
K. Hvidsten
P-07-312
Assessment of cavernosal arteries endothelial
function in diagnosis of arteriogenic erectile
dysfunction
Evsey Mazo, Russia
S. Gamidov, A. Stanislav, O. Ruslan,
V. Iremashvili
P-07-319
Cavernous blood flow regulates the level of
transforming growth factor G1 (TGF G1) in the
human corpus cavernosum
M. Mayer, C. Stief, F. Scheller,
U. Jonas, A. Becker
P-07-320
Improvements in erectile function and intercourse
success correlate positively with sexual relationship satisfaction assessed by the self-esteem
and relationship (sear) questionnaire in men
with erectile dysfunction receiving viagra®
(sildenafil citrate)
Vera J. Stecher, United States
L.-J. Tseng
P-07-321
Adhesion molecules sICAM-1 and sVCAM and
plasma levels of Von Willebrand factor are
increased in patients with erectile dysfunction
C. Vasiliadi, K. Rokkas, I. Dima,
N. Alexopoulos, M. Toutouza, A. Askitis,
C. Stefanadis, N. Loakeimidis
P-07-322
Aortic elastic properties are impaired in
patients with erectile dysfunction of vascular
origin and no clinical evidence of vascular
disease
N. Ioakeimidis, K. Rokkas,
N. Alexopoulos, K. Aznaouridis,
C. Fassoulakis, A. Askitis, C. Stefanadis
P-07-313
Erection and ejaculation preserving cystectomy
with orthotopic urinary diversion:
Is it feasible?
Mehmet Oder, Turkey
A. Sezer, M. O. Sahin, R. Aydin,
C. Dincel, C. Girgin
P-07-314
Development and validation of the quality of
erection questionnaire
C. Gilbert, S. Collins, X. Huang,
T. Symonds, V. Stecher
P-07-315
Factors affecting male sexual satisfaction in a
community based general medical practice
Matt Rosenberg, United States
C. Tallman, N. Sailor, D. Ohl,
M. Hazzard
P-07-323
The effects of serum testosterone and prolactin
on the sexual function
Sak Sei Chung, United Kingdom
P. Tirukonda, I. Eardley, O. Baldo
Review on clinical studies focussed on testosterone and ED including combination therapy with
PDE-V-inhibitors
Thomas Trinick, United Kingdom
P-07-324
Baseline potency in patients candidates for
bilateral nerve-sparing radical retropubic
prostatectomy
G. Zanni, A. Sacca, E. Farina,
F. Deho, N. Suardi, L. Barbieri,
A. Briganti, P. Rigatti, F. Montorsi,
A. Gallina
P-07-325
“Re-called” international index of erectile
function in patients with prostate cancer and
candidates to radical prostatectomy
A. Gallina, F. Fabbri, U. Capitanio,
N. Suardi, F. Deho, A. Briganti, E. Farina,
P. Rigatti, F. Montorsi, G. Zanni
P-07-316
P-07-317
Positive influence of sildenafil citrate on fertility ability in patients with sexual disturbanses
Romil Stanislavov, Bulgaria
V. Nikolova
P-07-318
Is erectile function affected by transrectal
prostate needle biopsy? Preliminary results
Altug Tuncel, Turkey
B. Uzun, U. Tekdogan, A. Atan
51
POSTER
P-07-326
52
Evaluation of the significance of the iief-erectile
function domain score as a clinical diagnostic
tool in patients with normal penile haemodynamics
K. Rokkas, T. Maga, A. Briganti,
L. Barbieri, F. Montorsi, N. Suardi,
F. Deho
P-07-327
Effects of KTP 532 photoselective vaporization
(PVP)(Greenlight) and TURP on erectile function:
A comparative study
E. Akkus, A. Erol
P-07-328
Evaluating Cardiovascular Safety of Viagra®
(Sildenafil Citrate) using spontaneous reports,
epidemiologic data, and clinical trials:
Converging lines of evidence
Rachel E. Sobel, United States
I. P. Levinson, R. F. Reynolds
P-07-329
C-reactive protein and pro-inflammatory
cytokines are elevated in men with erectile
dysfunction of vascular origin
Konstantinos Rokkas, Greece
C. Vlachopoulos, N. Ioakeimidis,
C. Vasiliadi, I. Dima, M. Toutouza,
A. Askitis, C. Stefanadis
P-07-330
Prospective study on erectile function in
patients undergoing prostate ultrasound guided
biopsy
C. Bettocchi, V. Mancini, I. Veneziano,
A. Saracino, P. Ditonno, M. Battaglia,
F. P. Selvaggi, V. Ricapito, V. Stellacci,
F. Boezio
P-07-331
The evaluation of erectile dysfunction in
patients with the history of pelvis fractures
Marek Draczynski, Poland
E. Pawlowska-Krajka, K. Krajka
P-07-332
Effectiveness of erectile dysfunction treatments
in treatment-naive patients: Results from the
Erectile Dysfunction Observational Study
(EDOS)
Alexander von Keitz, Germany
A. Riley, H. Buettner, J. Bertsch,
A. Beardsworth, S. Kontodimas
P-07-333
How does treatment of men with ED using a
phosphodiesterase type 5 inhibitor improve
their life in general?
O. Collins, J. Dean, P. Kell, G. Hackett,
D. Ralph, D. Edwards
P-07-334
Partners of heterosexual men with erectile
dysfunction, treated with vardenafil, feel themselves to be sexually more desirable
O. Collins, G. Hackett, D. Edwards,
J. Dean, D. Ralph, P. Kell
P-07-335
Web based information on erectile dysfunction
in English: Quality and popularity
Soliman Ewis, Qatar
H. Noureldin, N. Afifi
P-07-336
Intraoperative cavernous nerve stimulation for
evaluation of erectile response in patients
submitted to bilateral nerve-sparing radical
retropubic prostatectomy: report of preliminary
results
A. Briganti, C. Seif, A. Salonia,
E. Strada, C. Amiel, P. Rigatti,
K. P. Juenemann
P-07-337
Does treatment of patients diagnosed with
chronic prostatitis/chronic pelvic pain syndrome
affect sexual function?
Juza Chen, Israel
A. Greenstein, M. Sofer, N. Mabjeesh,
H. Matzkin
P-07-338
Therapeutic effectiveness of erectile dysfunction treatments: Results from the Erectile
Dysfunction Observational Study (EDOS)
Antonio Martin Morales, Spain
J. M. Haro, A. Beardsworth, J. Bertsch,
S. Kontodimas
P-07-339
Patient satisfaction and psychological and
interpersonal outcomes with erectile dysfunction treatments: Results from the Erectile
Dysfunction Observational Study (EDOS)
Antonio Martin Morales, Spain
J. M. Haro, A. Beardsworth, J. Bertsch,
S. Kontodimas
POSTER
P-07-340
Differential treatment responses to phosphodiesterase inhibition in a broad population of
men, with severe erectile dysfunction,
comprised of pre-defined patient subgroups
O. Collins, P. Kell, G. Hackett, J. Dean,
D. Edwards
P-07-341
Erectile dysfunction effect on quality of life
instrument (ED-EQoL): How useful is it?
O. Collins, J. Dean, G. Hackett,
I. Eardley, D. Edwards
P-07-342
The relationship between levels of satisfaction
expressed by erectile dysfunction patients treated with a phosphodiesterase Type 5 inhibitor,
and their partners
O. Collins, J. Dean, G. Hackett,
I. Eardley, P. Kell
P-07-343
Why do so many men from Islamic backgrounds
present with premature (rapid) ejaculation?
K. Wood, D. Goldmeier
P-07-344
The Impact of erectile dysfunction on the selfesteem, and other health and quality of life
related measures
Francisco Cabello, Spain
V. Chantada, F. Fora, A. Calle
P-07-345
Difficulties in achieving versus maintaining
erection: Organic, psychogenic and relational
determinants
M. Maggi, R. Mansani, R. Giommi,
G. Forti, F. Lotti, C. Krausz, G. Balercia
P-07-346
A live 3D system of ultrasonography and
Colour Doppler to study the effect of sildenafil
on erectile performance in recipients of renal
transplant presenting with erectile dysfunction
Ratna Chatterjee, United Kingdom
J. Deng, D. Pellerin, G. H. Neild,
W. R. Lees, C. R. Rodeck
P-07-347
Extraperitoneal laparoscopic ligation of veins of
periprostatic venous plexus for veno-occlusive
Peter Scheplev, Russia
Z. Kadirov, A. Aliev, N. Garin,
B. Gvasaliya
P-07-348
Patients and physicians expectations
regarding treatment of erectile dysfunction
R. Andrianne, T. Roumeguere,
B. Verheyden, K. Demyttenaere
P-07-349
Restoring the erectile function per penile training in patients after nerve-sparing radical
prostatectomy
P-07-350
The degree of “bother” perceived by patients
with erectile dysfunction is subjective and does
not predict responsiveness to treatment with a
PDE5 inhibitor
O. Collins, P. Kell, D. Ralph, J. Dean,
I. Eardley
P-07-351
First results from the “Kiel Concept” - rehabilitation following nerve sparing prostatectomy
A. Bannowsky, H. Schulze, C. Seif,
P. M. Braun, F. J. Martinez Portillo,
K. P. Juenemann
P-07-352
Interrelationships among erectile function,
sexual experience, satisfaction, and confidence
G. Jacob
53
LIST OF EXHIBITORS
EXHIBITOR
BOOTH NO.
BOOTH NO.
EXHIBITOR
AMS
1
1
AMS
Bayer HealthCare
8
2
Procter & Gamble
3
Mentor-Porges
4
Ipsen Pharma
5
Uroan 21
6
Schering AG
ESSM
European Society for Sexual Medicine
12
EAU
European Society of Urology
10
ESDA
European Sexual Dysfunction Academy
11
7
Lilly ICOS
Ipsen Pharma
4
8
Bayer HealthCare
Lilly ICOS
7
9
Pfizer Inc.
Mentor-Porges
3
10
Pfizer Inc.
9
EAU
European Society of Urology
Procter & Gamble
2
11
ESDA
European Sexual Dysfunction Academy
Schering AG
6
12
Uroan 21
5
ESSM
European Society for Sexual Medicine
Exhibition Floorplan
RESTAURANTS
SCHERING
6
4
AMS
1
IPSEN
Pharma
LILLY
ICOS
7
Mentor Porges
3
P&G
C
O
F
F
E
E
2
ESSM
12
PFIZER
Halls
A2/A3
BAYER
9
UROAN
8
Hall
A1
ESDA
5
11
EAU
POSTER EXHIBITION
10
INTERNET CENTRE
SPEAKERS
CENTRE
Auditorium
54
B
A
R
LIST OF CHAIRPERSONS
AND PRESENTERS
NAME
PAGE
A
Agrawal, V.
Akand, M.
Akkus, E.
Akman, T.
Aksit, S.
Alkhayal, S.
Andersson, K.-E.
Angulo, J.
Arsyad, K. M.
Athanasiadis, L.
Aversa, A.
27, 50
50
38
21, 49
43
44, 50
36
23, 25, 40
44
30, 36
25, 26, 36, 43
22,
34, 37, 42,
25,
27,
26,
43
48
41
29, 30
43, 45
24
35
42, 46
23,33
39, 44
37
30
31, 49
47
30, 35
C
Cabello, F.
Cai, Z.
Cakan, M.
Caruso, S.
Casella, R.
Chan, J.
Chantada, V.
Chatterjee, R.
Chaves, J.
Chen, J.
Chevret-Measson, M.
Chitale, S.
Chung, S. S.
Claes, H. I. M.
Coca, V.
Colombo, F.
Coman, I.
Corona, G.
Corretti, G.
Cuzin, B.
PAGE
46
24, 32, 49, 52
38
49
24, 51
31, 39, 43
45
21
44, 46, 50
28, 36, 44, 46, 53
44
22
D
B
Badalyan, R.
Bakurov, E.
Baltogiannis, D.
Barnes, T.
Basar, M.
Berner, M.
Bettocchi, C.
Bhatia, V.
Bivalacqua, T. J.
Boer, B.-J. de
Bonde, B.
Briganti, A.
Brock, G.
Burak Hopcan, M.
Buvat, J.
NAME
53
49
48
37
50
34
48
53
Daines, B.
Damsted Petersen, C.
Dean, J.
Delibas, M.
Demir, O.
Donabedian, D.
Draczynski, M.
30
33
26, 29, 30, 46, 53
37
24, 39, 40, 42, 44
34
52
E
Eardley, I.
Edmunds, N.
Elist, J.
Enzlin, P.
Erichsen, G.
Esen, A. A.
Esposito, K.
Ewis, S.
21, 25, 26, 28, 47, 50, 52
37
46, 50
28, 36, 53
45
46
35
50, 52
F
Falgaard Eplov, L.
Fisher, W. A.
Foresta, C.
Fugel-Meyer, A.
Fugl-Meyer, K.
Fusco, F.
39
28, 46, 50
35
21, 22
22, 28, 43
25
55
AND PRESENTERS
NAME
PAGE
G
Garaffa, G.
Gardner, K.
Garolla, A.
Gattuccio, I.
Gekas, A.
Gengo, P.
Giraldi, A.
Gittelman, M.
Giuliano, F.
Gizewski, E.
Glina, S.
Goldstein, I.
Gontero, P.
Grasso, M.
Graziottin, A.
Griffiths, J.
Gruenwald, I.
Guerrer, C. S.
Guirao, L.
56
PAGE
I
28,
26, 28, 29, 30, 36,
42,
21, 31,
27, 48
37
35
27
21, 49
24
30, 33
33, 42
40, 42
33
25
21
24
48, 49
30, 44
44
28, 33
43, 50
50
H
Hackett, G.
Hallam Jones, R.
Hartmann, U.
Hattat, H.
Hatzichristou, D.
Hatzimouratidis, K.
Hauck, E.
Hazell, L.
Hedlund, H.
Hedlund, P.
Heruti, R. J.
Horst, C. van der
Hotston, M.
Hulter, B.
NAME
37, 43,
28, 31,
27,
23,
41,
25, 32
30
22
50, 52
28
34, 50
30, 38
48
31
25, 33
39, 44
46, 53
40
37
Iconaru, V.
Isidori, A. M.
Ivanchenko, L.
48
36, 44
27
J
Jackson, G.
Jamieson, C.
Jannini, E.
Jay, L.
John, T.
Juenemann, K.-P.
Jun Ahn, G.
34, 35
42
30
48
27, 51
21, 47, 53
40
K
Kadiouglu, A.
Kalter-Leibovici, O.
Kamenov, Z.
Kaufman, J.
Kayes, O.
Keitz, A. von
Kell, P.
Kell, S.
Kendirci, M.
Kim, J. J.
King, R.
Kirby, M.
Klemmensen, Ä
Konstantinopoulos, A.
Krajka, K.
Krakovsky, A.
Kristensen, E.
Krueger, T.
Kumar, P.
Kun, A.
Kunelius, P.
45,
47,
26,
23, 27,
43,
21, 24,
24,
31, 40,
21
47
37
26
48
52
51
28
31
47
47
43
36
48
21
50
30
40
41
23
39
AND PRESENTERS
NAME
PAGE
L
Lecki, A.
Lehmann, V.
Leiblum, S.
Lemaire, A.
Lemos, M.
Letizia, P.
Levin, R.
Levinson, I.P.
Li, C.-Y.
Lin, W. Y.
Lombardi, G.
Longhi, E.
Lozano, A. F.
Lyngdorf, P.
PAGE
N
27,
28, 38,
27,
24,
43
45
33
45
45
50
45
34
41
28
43
37
28
35
M
Madsbad, S.
Maggi, M.
Mallet, R.
Mancini, M.
Mangiola, F.
Martin-Morales, A.
Mas, M.
Mattelaer, J.
Mazo, E.
McCullough, A. R.
Meryn, S.
Meuleman, E.
Minhas, S.
Mirone, V.
Mochida, H.
Modi, N.
Moncada, I.
Montorsi, F.
Montorsi, P.
Morelli, A.
NAME
28,
35, 38,
37, 45,
47,
34,
21,
22,
21, 31, 32, 34,
30, 32, 34, 45,
28,
23, 41,
35
33
43
34
43
52
47
32
51
48
22
30
35
23
34
42
39
52
39
42
Nedergaard, P.
Nehra, A.
Nilsson-Neijber, A.
Ny, L.
33, 37
34
42
26, 34, 46
O
Oder, M.
Ok Ahn, B.
Oldbring, J.
Omori, K.
Optale, G.
Ott, H. W.
51
40
22
40
37
45
P
Palumbo, F.
Papaharitou, S.
Park, K.
Park, N.C.
Passavanti, G.
Pechersky, A.
Perdzynski, W.
Perovic, S.
Pescatori, E. S.
Peterson, C.
Pfaus, J.
Pomara, G.
Porst, H.
Prasad Venkiteswaran, K.
Prieto, D.
Protogerou, V.
Pryor, J.
Pujos-Gautraud, M.
27, 52
33, 36, 37, 45
42
26
49
44
50
21, 31
22, 36
47
30
26
25, 26, 36, 51
43
23
21
22
39
R
Ralph, D.
Richardson, D.
21, 27, 53
24, 53
57
AND PRESENTERS
NAME
Richter, S.
Ridley, J.
Robinson, T.
Rokkas, K.
Rolle, L.
Romashchenko, O.
Rosen, R.
Rosenberg, M.
Rossello, M.
Roumeguere, T.
Rowland, D.
PAGE
32, 42
38
43
52
49
37
36
28, 51
47
39
22, 38
S
Saenz de Tajeda, I.
28, 32
Salonia, A.
24, 25, 28, 31, 33, 34, 36,
45, 51, 52
Santos, J.
40
Savoca, G.
38
Scheplev, P.
31, 53
Schiffer, B.
41
Schulman, C.
22
Schultheiss, D.
32
Sedigh, O.
49
Shaeer, O.
27, 50
Shechter, A.
45
Simonelli, C.
24, 38
Simonsen, U.
35
Sobel, R. E.
52
Sogni, F.
43
Sohn, M.
36, 46
Sonksen, J.
32
Stanislavov, R.
51
Startsev, V.
43, 44
Stauch, K.
47
Stecher, V. J.
51
Stien, R.
32
Suh, J.-K.
23
Summerton, D.
49
Sungur, M.
38
Symonds, T.
28
Sytenko, A.
48
58
NAME
PAGE
T
Talseth, T.
Tomlinson, J.
Tremeaux, J.-C.
Trinick, T.
Tuncel, A.
24,
31,
35,
47,
38
30
49
51
51
U
Ueckert, S.
Usta, M. F.
37, 42, 51
23, 41
V
Valiquette, L.
Vardi, Y.
Ver Heiden, B.
Verze, P.
Vetri, M.G.
Villalba, N.
Vlachiotis, J.
Vlachopoulos, C.
47
25, 33, 37
32
45
36
40
21, 48
26, 51
W
Wagner, G.
Waldinger, M. D.
Waldkirch, E.
Wang, W.
Wayman, C.
Werkström, V.
Wespes, E.
Wilson, L.
Wirsam, K.
Wylie, K.
Wyllie, M.
22, 32
22, 29, 38
33, 34, 40
41
28, 40, 41
46
31
30
31
30, 38
42
Y
Yassin, A.
24, 36, 44, 48, 53
Z
Zhu, H.
Ziegler, D.
Zucchi, A.
27, 48
34
34
9th Congress of the European Society
for Sexual Medicine
3 - 6 December 2006
Vienna, Austria
www.essm.org
See you in
VIENNA 2006!
Anzeige Pfizer
linke Seite

TABLE OF CONTENTS

Transcription

Similar documents

Media : Metro Ahad Section : Setempat Date

L`ombelico del mondo

Contemporary blue design template

Advances in the Treatment of Erectile Dysfunction

SEXtend \seks tend \ - Student Health Center

Tracey Cox - Men`s Health Forum

Erectile dysfunction and treatment options

Intimissimi has a great history behind it. The extraordinary